← Back
Clinical Medicine and Surgery I · Exam 7 · Class of 2028

CMS I Exam 7 Cram Sheet

The study focus the lecturer posted comes first, then criteria, scores and classifications: one table per set from the slides, each with a labeled memory aid. Respiratory Block Exam II, condensed from the Exam 7 study guide. Lectures covered: 39 (phases of sleep), 40 (obstructive sleep apnea and obesity hypoventilation syndrome), 41 (inflammatory lung diseases), 42 (pulmonary vascular disease), 43 (pulmonary nodules and neoplasms), 44 (pleural disorders), 45 (acid-base part II). Each lecture opens with a gold card of what its lecturer stressed (starred; from the recording once it is in); every fact still comes from the slides.

Study Focus Criteria & Scores (Lectures 39–45) ★ Emphasized: Sleep Physiology REM vs Non-REM Sleep Why We Sleep & the Sleep-Wake Cycle ★ Emphasized: Sleep Apnea Obstructive Sleep Apnea Treating Obstructive Sleep Apnea Untreated: Complications & Comorbidities Central Sleep Apnea Obesity Hypoventilation Syndrome ★ Professor Emphasized — Inflammatory Lung Disease Interstitial Lung Disease: the Common Ground Idiopathic Interstitial Pneumonia & Pulmonary Fibrosis Connective Tissue & Granulomatous Disease Sarcoidosis Hypersensitivity Pneumonitis Acute Respiratory Distress Syndrome ★ Professor Emphasized — Pulmonary Vascular Disease Cor Pulmonale Pulmonary Hypertension Pulmonary Edema Pulmonary Embolism Adults vs the Elderly; Referral ★ Professor Emphasized — Pulmonary Nodules & Neoplasms Pulmonary Nodule: Finding and Working It Up Lung Cancer: Who, Why, How It Spreads Presentation and Metastatic Signs Adenocarcinoma, Large Cell, Squamous Cell Small Cell Carcinoma & Radiotherapy Paraneoplastic Syndromes & Carcinoid Adults, Older Adults & Referral ★ Professor Emphasized — Pleural Disorders The Pleura & Pleurisy Spontaneous Pneumothorax: Picture Pneumothorax Imaging The Procedures Toolbox After the Pneumothorax: Education Traumatic & Tension Pneumothorax Hemothorax Pneumomediastinum Pleural Effusion: Picture Effusion Workup Exudates: Chylothorax & Empyema Transudates & Treating an Effusion Pleurodynia (Bornholm Disease) ★ Professor Emphasized — Acid-Base Disorders II Definitions, Buffers & Electrolytes Stepwise Method Respiratory Acidosis Respiratory Alkalosis Metabolic Acidosis Metabolic Alkalosis
How to use this: this is a condensed, night-before-the-exam reference, not a replacement for the full study guide — it assumes you've already learned the material and just need the highest-yield facts at a glance. If a term feels unfamiliar, go back to the full guide for the explanation.

Study Focus: Pulmonary Nodules & Neoplasms (slide 49, “Things to Know”)Study focus · Lecture 43 · slide 49 (his own exam list)

Things to Know (slide 49)The answer, from the slides
The criteria for screening an asymptomatic and at-risk patientNo symptoms, no known nodule; 55–80; at least 30 pack-years; smokes now or quit within 15 years → annual low-dose chest CT (computed tomography)
A benign nodule’s appearanceWell-defined borders, fat (hamartoma), calcification (diffuse, central, popcorn = hamartoma, concentric), next to a fissure; under 6 mm and not high risk
What makes you concerned for a malignant noduleOver 6 mm; upper lobe or hilar; spiculated (spiky border); more than 3; enlarging; contrast-enhancing; cavitated or nonsolid; high-risk patient; ground-glass or eccentric calcification
Staging by size, nodes and metastasis (TNM), and how it changes treatmentN2 or N3 = stage 3; M1 = stage 4. Non-small cell: stages 1–2 surgical resection, stage 4 chemotherapy; chemotherapy and radiation are adjuncts (non-small cell responds poorly)
Which cancers are peripheral or centralCentral: small cell and squamous cell. Peripheral: adenocarcinoma and large cell
Recognize squamous cell among the non-small cell cancersStrongest smoking link; central, from a bronchus; cough, wheezing, hemoptysis; cavitation; caught by sputum cytology; hypercalcemia
Recognize small cell lung carcinoma (SCLC)Oat cell; central; over 70% metastatic before detection; neuroendocrine paraneoplastic syndromes (SIADH, syndrome of inappropriate antidiuretic hormone); no nucleoli, high nuclear-to-cytoplasm ratio, crushed at biopsy
Which cancer benefits most from radiotherapySmall cell: responds better to chemotherapy and radiation than the non-small cell types; best in limited stage; prophylactic cranial irradiation
Paraneoplastic signs (“i.e. small cell”)SIADH: low sodium and osmolality → confusion, seizures, ataxia, no edema; hypercalcemia (squamous); Lambert-Eaton leg weakness; carcinoid syndrome (bronchial carcinoid)
Memory aid

Screen, Smooth, Spiky, Stage, Site, Squamous, Small, Shoot (radiation), Syndromes: nine S’s for nine bullets.

Screen screening criteriaSmooth benign appearanceSpiky concerning nodule (spiculated)Stage TNM and its treatmentSite central or peripheralSquamous recognize squamous cellSmall recognize small cellShoot radiotherapy benefits small cell mostSyndromes paraneoplastic signs

Where it breaks: “Smooth” stands for all the benign signs (fat, calcification, fissure), not only smooth borders.

The Four EEG WaveformsClassification · Lecture 39 · slides 21–26

WaveFrequency (cycles/second)Where and when
BetaGreater than 14 (as high as 80)Parietal and frontal regions; asynchronous, low voltage; awake, alert, actively processing information
Alpha8–13, rhythmicalHealthy adults awake, quiet and resting; most intense occipital; disappear in deep sleep; replaced by beta when attention is directed to a task
Theta4–7Parietal and temporal regions in children; emotional stress in some adults (disappointment, frustration); degenerative brain disorders
DeltaLess than 3.5Voltage 2–4 times other waves; strictly cortical; very deep sleep, infancy, serious organic brain disease, cortex cut off from the thalamus
Memory aid

Fastest to slowest the waves spell BAT-D: Busy, At rest, Tired, Deep.

B Beta: busy, alert, actively processing (>14)A Alpha: awake but at rest, quiet (8–13)T Theta: tired (light sleep), children, stress, brain disorders (4–7)D Delta: deep sleep, infancy, organic brain disease (<3.5)

Where it breaks: “Tired” covers only theta’s sleep use; its children, stress and brain-disorder settings must be learned separately.

EEG by Stage of Wakefulness and SleepStaging · Lecture 39 · slide 28 (with 27, 29)

StageWhat happensEEG
Awake, eyes openAlert and activeBeta
Awake, eyes closedDecreased alertness, relaxationAlpha
N1Transition from wakefulness; drowsy; light sleepTheta
N2Deeper sleep; heart rate and temperature fall; longest stage by total durationTheta; sleep spindles (12–14 Hz bursts); K complexes (negative sharp wave then positive component)
N3 (deep, slow-wave)Deepest non-REM stage; harder to arouse; growth and repair; decreases with ageDelta
REM (stage R)Dream state; rapid, irregular eye movements; atonia except eyes and diaphragm; sawtooth wavesBeta (like awake, with atonia)
Slide 27 and the slide 29 picture use FOUR non-REM stages and put spindles in stage 1; the slide 28 table (above) uses three and puts spindles in N2.
Memory aid

BATTeD, then Back: down the night the waves go Beta, Alpha, Theta, Theta, Delta, and REM goes Back to beta.

B Eyes open: betaA Eyes closed: alphaT N1: thetaT N2: theta (+ spindles, K complexes)D N3: deltaBack REM: back to beta, with atonia

Where it breaks: The vowel “e” in BATTeD stands for nothing.

Sleep by the NumbersCut-offs · Lecture 39 · slides 6, 9, 10, 12

MeasureValue
Average sleep8 hours
Cycles per night4–5
Length of one cycle90–120 minutes
REM share of a young adult’s sleepAbout 25%
REM episodesRecur about every 90 minutes; each lasts 5–30 minutes
Non-REM fall in blood pressure, heart rate, breathing, metabolic rate10–30%
REM rise in brain metabolismUp to 20%
Memory aid

8 hours, 4–5 laps of 90: a quarter of it dreaming.

8 hours of sleep on average4–5 cycles90 minutes: cycle length starts at 90 (to 120) and REM recurs every 90A quarter REM is about 25% of a young adult’s sleep

Where it breaks: Leaves out the 5–30 minute REM episode, the 10–30% non-REM fall and the 20% REM rise: learn those from the table.

Apnea, Hypopnea and the Three Apnea TypesDefinitions · Lecture 40 · slide 3

TermAirflowRespiratory effort
ApneaDecrease of 90% or more (thermistor), lasting at least 10 seconds—
HypopneaSlowed, shallow, restricted breathing in episodes of 10 seconds or longer—
Obstructive apneaNoneContinued
Central apneaNoneNone
Mixed apneaNoneAbsent early in the event, resumes later
Memory aid

Ninety for Ten; then ask the chest: Obstructive keeps On trying, Central has Ceased, Mixed Makes up its mind late.

90 / 10 apnea: airflow down 90% or more for 10 seconds or moreO Obstructive: effort ongoingC Central: effort ceasedM Mixed: effort missing, then made

Where it breaks: Hypopnea has no percentage on the slide, only the 10-second episodes.

Obstructive Sleep Apnea: Diagnostic Criteria and IndicesCriteria · Lecture 40 · slide 9

ItemWhat the slide says
Criterion 15 or more predominantly obstructive respiratory events per hour of sleep plus one symptom: sleepiness, fatigue, insomnia or impaired sleep-related quality of life; waking with breath holding, gasping or choking; habitual snoring or breathing interruptions seen by a bed partner
Criterion 215 or more predominantly obstructive respiratory events (no symptom needed; the slide gives no time unit here)
AndSymptoms not explained by another medical or sleep condition, medications or substance use
Apnea-hypopnea index(apneas + hypopneas) ÷ total sleep time in hours
Respiratory disturbance index(apneas + hypopneas + respiratory effort-related arousals) ÷ total sleep time in hours
Mild, moderate and severe index bands appear only in the speaker notes, not on a slide.
Memory aid

Five needs a friend; fifteen stands alone.

5 5 or more events per hour needs one symptom15 15 or more events is enough on its own (no time unit on the slide)

Where it breaks: Both still need the symptoms to be unexplained by another condition, drug or substance.

STOP-Bang QuestionnaireScore · Lecture 40 · slides 16–17

LetterYes if (1 point each)
SnoringSnores loudly (through closed doors, or the bed partner elbows you)
TiredOften tired, fatigued or sleepy in the daytime
ObservedSomeone observed you stop breathing, or choking or gasping, during sleep
PressureHave, or being treated for, high blood pressure
BMIBody mass index more than 35 kg/m²
AgeOlder than 50
NeckNeck (shirt collar) 16 inches / 40 cm or larger
GenderMale
RISK (general population)
LowYes to 0–2
IntermediateYes to 3–4
HighYes to 5–8, or 2 or more of the 4 STOP questions plus male gender, or plus body mass index over 35, or plus neck 16 inches / 40 cm
Not for routine community screening or asymptomatic patients; used preoperatively; the highest sensitivity of the questionnaires (slide 16). The risk-factor neck size on slides 6–7 is 17 inches (men) / 16 (women).
Memory aid

The name is the mnemonic: STOP (four symptoms) and Bang (four facts).

S Snoring loudlyT Tired in the daytimeO Observed apneas, choking or gaspingP Pressure: high blood pressureB BMI over 35A Age over 50N Neck 16 inches / 40 cm or moreG Gender male

Where it breaks: Risk bands 0–2 / 3–4 / 5–8 and the 2-STOP-plus rules are not in the name: learn them from the table.

Home Sleep Test or In-Lab Polysomnogram?Criteria · Lecture 40 · slide 8

Use a polysomnogram, NOT a home kit, with:
Stroke
Neuromuscular weakness
Long-term opioid use
Significant cardiopulmonary disease
Awake hypoventilation or hypoxemia
Severe insomnia
Concern for a non-obstructive sleep disorder
Home kits assess only obstructive sleep apnea and will not always diagnose mild disease (helpful for moderate to severe). Central sleep apnea: home testing is not sufficient (slide 26).
Memory aid

A SNOCHIN (a snoring chin) with any of these sleeps in the lab.

S StrokeN Neuromuscular weaknessO Opioids, long termC Cardiopulmonary diseaseH Hypoventilation or hypoxemia while awakeI Insomnia, severeN Non-obstructive sleep disorder suspected

Where it breaks: Made up here; the slide lists them in a different order.

Obesity Hypoventilation Syndrome: Screen, Diagnose, TreatCriteria · Lecture 40 · slides 31–33

StepWhat the slides say
SCREEN an obese patient (with or without obstructive sleep apnea) who has
Oxygen saturationUnexplained awake room-air saturation 94% or less, or overnight lowest below 80%
Symptoms and signsUnexplained dyspnea on exertion; pulmonary hypertension or right-sided heart failure (elevated jugular venous pressure, hepatomegaly, pedal edema); facial plethora (facial swelling, puffiness)
LabsRaised bicarbonate; when suspicion is low to moderate, serum bicarbonate over 27 → arterial blood gas
DIAGNOSE by exclusion: all three
1Obesity: body mass index over 30
2Awake alveolar hypoventilation: arterial carbon dioxide pressure over 45 mm Hg
3Alternative causes of hypercapnia and hypoventilation excluded
Gold standardPolysomnography with continuous nocturnal carbon dioxide monitoring
TREAT
ApproachMultidisciplinary
First lineWeight loss program + positive airway pressure: with obstructive sleep apnea → CPAP; with sleep-related hypoventilation → BiPAP
LifestyleDiet changes, exercise, behavioral modifications
Second lineTracheostomy with nocturnal ventilation (very effective); bariatric surgery; medications only after diet and exercise fail
Memory aid

Screen at 94-80-27; diagnose at 30-45-zero.

94 awake saturation 94% or less80 overnight nadir below 80%27 bicarbonate over 27 means get a blood gas30 body mass index over 3045 arterial carbon dioxide over 45 mm Hgzero zero other causes (diagnosis of exclusion)

Where it breaks: The screening signs without numbers (dyspnea, right heart failure, facial plethora) and the treatment rows (multidisciplinary, first line, lifestyle, second line) are not in the numbers.

Untreated Obstructive Sleep Apnea: the NumbersCut-offs · Lecture 40 · slides 18–20

OutcomeRisk
Driving accidents2.5 times
Sudden cardiac death AT NIGHT3–6 times
Hypertension3 times
Nonalcoholic fatty liver disease (prevalence)2–3 times
Gastroesophageal or laryngopharyngeal reflux75–100% of patients; improves with CPAP
Memory aid

Count up the night: 2.5 crashes, 2 to 3 livers, 3 pressures, 3 to 6 hearts stop, and nearly all reflux.

2.5 driving accidents2–3 fatty liver3 hypertension3–6 sudden cardiac death at night75–100% reflux

Where it breaks: Heart failure mortality, pulmonary hypertension, stroke, arrhythmias and ischemic heart disease carry no number on the slides.

Interstitial Lung Disease: Onset PatternsClassification · Lecture 41 · slide 22

OnsetTime courseTypical of
AcuteDays to weeksAllergy
SubacuteWeeks to monthsAny, but most common with sarcoidosis and drug-induced disease
ChronicMonths to yearsMost interstitial lung diseases: idiopathic pulmonary fibrosis, sarcoidosis, pneumoconiosis, connective tissue disease
EpisodicLess commonHypersensitivity pneumonitis
Memory aid

All Sorts Come Eventually: Allergy fast, Sarcoid and drugs Sub, Chronic for most, hypersensitivity comes and goes (Episodic).

A Acute (days to weeks): allergyS Subacute (weeks to months): sarcoidosis, drug-inducedC Chronic (months to years): most, including idiopathic pulmonary fibrosis, sarcoidosis, pneumoconiosis, connective tissue diseaseE Episodic: hypersensitivity pneumonitis

Where it breaks: Sarcoidosis sits in both the subacute and the chronic rows on the slide.

Reading the Film and the Pulmonary Function TestsClassification · Lecture 41 · slides 26, 29

FindingMeaning
RETICULAR (curvilinear) OPACITIES
Fine (ground glass)Early finding
Medium (honeycombing)Late finding
CoarseCystic spaces
OTHER PATTERNS
NodularNodules
ReticulonodularReticular shadows overlapping, or with nodules (sarcoid)
Hilar and mediastinal lymphadenopathySarcoidosis, silicosis
RESTRICTIVE PATTERN
Forced expiratory volume in 1 second ÷ forced vital capacityNormal or increased
Total lung capacity and forced vital capacityDecreased
Memory aid

Ground glass Goes first, Honeycomb Hangs on late; in restriction the Ratio is Retained while the volumes are Reduced.

G ground glass = fine, earlyH honeycombing = medium, lateCoarse cystic spacesRatio retained normal or increased ratioVolumes reduced total lung capacity and forced vital capacity decreased

Where it breaks: The other patterns (nodular, reticulonodular, hilar adenopathy in sarcoidosis and silicosis) have no letter.

Laboratory Clues in Interstitial Lung DiseaseClassification · Lecture 41 · slide 25

TestPoints to
Sedimentation rate increasedActive sarcoidosis
High antinuclear antibodyCollagen vascular disease
c-ANCA (cytoplasmic antineutrophil cytoplasmic antibody)Granulomatosis with polyangiitis
Anti-glomerular and anti-alveolar basement membrane antibodiesGoodpasture syndrome (glomerulonephritis + diffuse pulmonary hemorrhage, young adults)
Elevated angiotensin-converting enzymeSarcoidosis; the slide also writes “hypersensitivity silicosis”
EosinophiliaEosinophilic pneumonia, sarcoidosis, drug-induced
Slide 44: the angiotensin-converting enzyme is elevated in 40–80% of sarcoidosis patients.
Memory aid

Sarcoid has the ACE (angiotensin-converting enzyme) and the Sed rate; GPA (granulomatosis with polyangiitis) is C-ANCA; Goodpasture hits the Basement (lung and kidney); ANA means Autoimmune.

ACE + Sed sarcoidosis (active)C-ANCA granulomatosis with polyangiitisBasement anti-basement membrane: GoodpastureANA collagen vascular (autoimmune) disease

Where it breaks: Eosinophilia (three causes) and the slide’s “hypersensitivity silicosis” beside the enzyme are not in the hook.

Idiopathic Pulmonary Fibrosis Without a BiopsyCriteria · Lecture 41 · slide 35

#In a patient over 65 (all four = 90% confidence, no surgical lung biopsy)
1Idiopathic disease by history, with inspiratory crackles on examination
2Restrictive physiology on pulmonary function testing
3Radiographic evidence of progressive fibrosis over several years
4Diffuse, patchy fibrosis with pleural-based honeycombing on high-resolution CT
Corticosteroids may be used in cryptogenic organizing pneumonia, lymphoid interstitial pneumonia and nonspecific interstitial pneumonia (slide 38); for idiopathic pulmonary fibrosis nothing has improved survival and smoking cessation is critical (slide 37).
Memory aid

Over 65 and CRPH (crackles, restriction, progression, honeycomb): skip the biopsy.

C Crackles (inspiratory) in idiopathic diseaseR Restrictive physiologyP Progressive fibrosis over years on filmsH Honeycombing, pleural-based, on high-resolution CT

Where it breaks: The age (over 65) is outside the four letters.

Sarcoidosis: Chest Film StagesStaging · Lecture 41 · slides 45, 48

StageChest film
IBilateral hilar adenopathy alone
IIHilar adenopathy and parenchymal involvement
IIIParenchymal involvement alone (diffuse reticular infiltrates)
IVAdvanced fibrosis: honeycombing, hilar retraction, bullae, cysts, emphysema
Best prognosis with hilar adenopathy alone; parenchymal involvement is worse; 20% with lung involvement get irreversible impairment (slide 48). Biopsy whenever lymphoma or another diagnosis is possible (slide 45).
Memory aid

Nodes, Nodes + lung, Lung, Scar.

I nodes (hilar adenopathy) aloneII nodes + lungIII lung aloneIV scar (fibrosis, honeycombing)

Sarcoidosis: When to Give Oral CorticosteroidsCriteria · Lecture 41 · slides 46–47

Indication (slide 47)Organ
HypercalcemiaCalcium
Cardiac involvementHeart
Iritis, uveitisEyes
Granulomatous hepatitisLiver
Progressive pulmonary lesionsLungs (progressive)
Cutaneous lesions other than erythema nodosumSkin
ArthritisJoints
Central nervous system involvementBrain
Disabling constitutional symptomsConstitution
About 90% respond to corticosteroids. Intolerant or refractory: methotrexate, azathioprine or infliximab (slide 46).
Memory aid

Calcium HELPS JB’s Constitution.

C Calcium: hypercalcemiaH Heart: cardiac involvementE Eyes: iritis, uveitisL Liver: granulomatous hepatitisP Progressive pulmonary lesionsS Skin lesions other than erythema nodosumJ Joints: arthritisB Brain: central nervous system involvementConstitution disabling constitutional symptoms

Where it breaks: Erythema nodosum alone is the skin exception: it is NOT an indication.

The Dust Diseases Side by SideClassification · Lecture 41 · slides 50–64

Coal workers’ pneumoconiosisAsbestosisSilicosis
ExposureCoal dustInsulation, demolition, shipyards, construction (10–20 years; seen about 15 years later)Mining, sandblasting, quarry, stone work (crystalline silica)
WhereUpper lung fieldsBasesUpper lobes (lighter dust)
HallmarkCoal macules 2–5 mmPleural plaques (most common film finding); ferruginous bodies; CT preferredSilicotic nodules 1–10 mm; eggshell calcification of hilar nodes; milky lavage
FunctionRestrictive, reduced diffusing capacityReduced vital capacity and total lung capacityReduced forced vital capacity and forced expiratory volume
Watch forProgressive massive fibrosisLung cancer (smokers) and mesothelioma (10% lifetime)Tuberculosis (skin test + current chest film), progressive massive fibrosis, scleroderma
TreatmentSupportive: oxygen, vaccines, rehabilitation, stop smoking; transplantSupportive: fibers cannot be removedSupportive; stop smoking
Memory aid

Coal and silica float UP, asbestos sinks DOWN; asbestos Plants Plaques and Mesothelioma, silica brings Tuberculosis and Eggshells.

Up coal (upper fields) and silica (upper lobes)Down asbestos (bases)Plaques + mesothelioma asbestosTuberculosis + eggshells silica

Where it breaks: The hook leaves out the coal macules (2–5 mm), the silicotic nodules, progressive massive fibrosis (coal and silica), lung cancer, scleroderma, and the function and treatment rows.

Hypersensitivity Pneumonitis: Acute, Subacute, ChronicClassification · Lecture 41 · slides 66–67

TypeTimingSigns and symptoms
AcuteWithin 9 hours of exposureFlu-like illness (fever, chills, muscle or joint pain, headache), rales, cough
SubacuteMultiple exposures (15%)Rales, cough, chronic bronchitis, shortness of breath, anorexia or weight loss
ChronicMultiple exposures (5%)Cough, chronic bronchitis, shortness of breath, anorexia or weight loss, fatigue, lung fibrosis, clubbing
Slide 66: symptoms, with nausea 4–8 hours after exposure; slide 67: acute disease within 9 hours of exposure.
Memory aid

Acute is the Flu; chronic adds the three Fs: Fatigue, Fibrosis, Fingers (clubbing).

Flu acute: flu-like illness, rales, coughFatigue chronic onlyFibrosis chronic onlyFingers clubbing, chronic only

Where it breaks: Subacute has no letter: it sits between (rales, cough, bronchitis, dyspnea, weight loss).

Acute Respiratory Distress Syndrome: Criteria and SeverityCriteria · Lecture 41 · slide 73 (picture)

ItemWhat the picture says
CORE DIAGNOSTIC CRITERIA
Acute onsetDevelops within 7 days of a known clinical insult
Bilateral opacitiesNew opacities not explained by effusion, atelectasis or nodules
Non-cardiogenicFailure not fully explained by heart failure or fluid overload
OxygenationArterial oxygen pressure ÷ fraction of inspired oxygen under 300 mm Hg (or saturation ÷ fraction under 315)
SEVERITY (arterial oxygen pressure ÷ fraction of inspired oxygen)
Mild200–300 mm Hg
Moderate100–200 mm Hg
SevereUnder 100 mm Hg
Example: arterial oxygen 60 mm Hg on 50% oxygen (0.5) = 120, moderate. The management picture (slide 74) gives plateau pressure “under 50 cm H2O”, which differs from current guidelines (see the guide note); no question keys the number.
Memory aid

A-R-D-S: Acute, Radiograph, Doesn’t come from the heart, Short of oxygen; then grade by 3-2-1 hundred.

A Acute: within 7 days of an insultR Radiograph: bilateral opacities not from effusion, atelectasis, nodulesD Doesn’t come from the heart: not fully explained by heart failure or fluid overloadS Short of oxygen: ratio under 3003-2-1 mild 200–300, moderate 100–200, severe under 100

Acute vs Chronic Cor PulmonaleClassification · Lecture 42 · slide 9

Acute cor pulmonaleChronic cor pulmonale
Primary etiologyMassive pulmonary embolismCOPD, ILD, PAH (chronic obstructive pulmonary disease, interstitial lung disease, pulmonary arterial hypertension)
Time courseMinutes to hoursMonths to years
Right ventricular adaptationSudden dilation & dysfunctionConcentric hypertrophy followed by late dilation
Classic presentationSevere sudden dyspnea, sweating, rapid pulse, pallor, syncopeUnproductive cough, progressive exertional dyspnea, “Blue Bloater” phenotype
Key hemodynamic threatDecreased left ventricular filling & immediate cardiovascular collapse (shock)Progressive volume overload, hypoxemia, and right heart failure
Slide 4: cor pulmonale = elevated mean pulmonary artery pressure with a NORMAL wedge pressure; left heart failure (Group 2) is not cor pulmonale.
Memory aid

Acute Dilates, Chronic Concentrates: a sudden clot gives the thin right ventricle no time to grow, so it balloons; years of lung disease let it thicken first.

Acute massive embolism, minutes to hours, sudden dilation, shockChronic COPD, ILD, PAH; months to years; concentric hypertrophy, late dilation

Where it breaks: Chronic disease still ends in dilation (“late dilation”).

Sorting Pulmonary Hypertension: the Diagnostic FunnelsAlgorithm · Lecture 42 · slides 12, 24

Step / testWhat it doesResult
COR PULMONALE / PULMONARY HYPERTENSION PATHWAY (slide 12)
1. Chest X-ray & pulmonary function testsInterstitial markings or hyperinflation vs clear fields; obstructive vs restrictiveLung disease → Group 3
2. V/Q (ventilation/perfusion) scan or CT pulmonary angiographyExclude segmental defects (chronic thromboembolic disease, embolism)Defects → Group 4
3. Right heart catheterization & echoConfirm right ventricular strain, measure hemodynamicsElevated mean pulmonary artery pressure, wedge ≤15 mmHg → Group 1
SCREEN, DIFFERENTIATE, CONFIRM (slide 24)
EchocardiographyThe most useful initial test: right ventricular size, TAPSE (tricuspid annular plane systolic excursion), pulmonary pressures; finds left-sided mimicsScreening
V/Q scanEssential test to exclude CTEPH (chronic thromboembolic pulmonary hypertension); do not rely on CT angiography aloneHigh-probability mismatch → surgical pathway (thromboendarterectomy)
Right heart catheterization“The mandatory gold standard”: mean pulmonary artery pressure, wedge pressure, pulmonary vascular resistanceConfirms pre-capillary pulmonary hypertension
Memory aid

Lungs, then Clots, then the Catheter: each step takes one group off the table, and what is left is Group 1.

Lungs chest film + pulmonary function tests → Group 3Clots V/Q or CT pulmonary angiography → Group 4Catheter right heart catheterization + echo → Group 1 (wedge ≤15)

Where it breaks: Echo is the first test in practice (slide 24, screening) even though it sits in step 3 of slide 12.

Pulmonary Hypertension: World Health Organization (WHO) GroupsClassification · Lecture 42 · slide 19

GroupMechanismExamples
PRE-CAPILLARY
Group 1 (PAH) pulmonary arterial hypertensionObliterative / proliferativeIdiopathic, connective tissue disease, HIV (human immunodeficiency virus), schistosomiasis
Group 3 (lung disease / hypoxia)(not keyed)COPD (chronic obstructive pulmonary disease), interstitial lung disease, sleep apnea
Group 4 chronic thromboembolic pulmonary hypertension (CTEPH)ObstructiveChronic thromboembolic occlusion
POST-CAPILLARY
Group 2 (left heart disease)PassiveObstruction to pulmonary venous outflow (heart failure with reduced or preserved ejection fraction, mitral stenosis)
DRAWN APART
Group 5 (unclear / multifactorial)ComplexHematologic, systemic, metabolic disorders (e.g., sarcoidosis)
Slide 19 prints a venous mechanism for Group 3; slides 6 and 15 explain it by hypoxic vasoconstriction. Only Group 2 is post-capillary.
Memory aid

Arteries, Heart, Lungs, Clots, Unclear: “A Heart Loves Clean Understanding.” (His version: 1 arterial, 2 left heart, 3 lung, 4 clots.)

A (1) arterial: pulmonary arterial hypertensionH (2) left heart disease (post-capillary)L (3) lung disease / hypoxiaC (4) clots: chronic thromboembolicU (5) unclear / multifactorial (sarcoidosis)

Where it breaks: The hook does not tell you which groups are pre-capillary (1, 3, 4) and which is post-capillary (2).

Pulmonary Hypertension: Symptoms by Functional ClassStaging · Lecture 42 · slide 21

Stage (World Health Organization class)Symptoms
Early / mild (I–II)Exertional dyspnea and fatigue: often the only early symptom; misattributed to deconditioning
Moderate (III)Dizziness, lightheadedness; marked limitation of physical activity
Severe (IV)Syncope/presyncope = ominous (a fixed, low cardiac output that cannot rise with exertion); end-stage abdominal bloating, early satiety, edema; present even at rest
Memory aid

Walk, Wobble, Wipe-out: breathless on walking (I–II), dizzy (III), fainting and full of fluid at rest (IV).

Walk exertional dyspnea, fatigue: class I–IIWobble dizziness, lightheadedness: class IIIWipe-out syncope, bloating, early satiety, edema at rest: class IV

Where it breaks: The slide 25 risk table gives “occasional syncope” to the intermediate tier (class III); repeated syncope is high risk.

Left Heart Failure vs Right Heart Failure / Cor PulmonaleClassification · Lecture 42 · slide 23

Left heart failureRight heart failure / cor pulmonale
Predominant symptomsOrthopnea, paroxysmal nocturnal dyspneaAbdominal bloating, early satiety, profound fatigue, exertional syncope
Lungs & chest X-rayBibasilar crackles, wheezing, Kerley B lines, pleural effusionsLungs typically clear; enlarged central pulmonary arteries with peripheral pruning
Key hemodynamicsWedge pressure >15 mmHgNormal/low wedge (≤15 mmHg) with elevated mean pulmonary arterial pressure
Slide 33 draws its edema line at 18 (cardiogenic >18–20, noncardiogenic ≤18); each cut-off answers its own question.
Memory aid

Left = Lungs wet; Right = the Rest (belly, liver, legs) wet and the lungs dry.

Left orthopnea, crackles, Kerley B, effusions, wedge >15Right bloating, satiety, clear lungs, pruned periphery, wedge ≤15

Where it breaks: The hook does not hold the number: 15 mmHg is the split on this slide.

Pulmonary Hypertension Prognostic Risk (1-Year Mortality)Score · Lecture 42 · slide 25

DeterminantLow (<5%)Intermediate (5–10%)High (>10%)
Signs of right ventricular failureAbsentAbsentPresent
ProgressionSlowModerateRapid
SyncopeNo syncopeOccasionalRepeated
WHO (World Health Organization) functional classI or IIIIIIV
6-minute walk distance>440 m165–440 m<165 m
Memory aid

Learn the middle (his rule): class III, occasional syncope, moderate progression, 165–440 m. Better is low, worse is high; right ventricular failure signs = automatically high.

Middle intermediate 5–10%Right ventricular failure signs high risk, >10%440 / 165 the walk-distance edges

Where it breaks: Right ventricular failure signs are absent in BOTH low and intermediate, so they only separate high from the rest.

Pulmonary Arterial Hypertension Drug PathwaysClassification · Lecture 42 · slide 26

PathwayActionExamples
Endothelin receptor antagonistsBlock endothelin-1: no potent vasoconstriction, no smooth muscle proliferationAmbrisentan, bosentan, macitentan
★ Phosphodiesterase-5 inhibitorsPrevent cGMP (cyclic guanosine monophosphate) breakdown, enhancing the nitric oxide pathway: smooth muscle relaxationSildenafil, tadalafil
Prostacyclins / IP receptor agonistsIncrease cAMP (cyclic adenosine monophosphate); most potent class for vasodilation and anti-platelet aggregation; essential for severe diseaseEpoprostenol, treprostinil, iloprost, selexipag
Memory aid

Read the suffix: -AFIL = phosphodiesterase-5 (his “AFILs”); -SENTAN = endothelin; PROST in the name = prostacyclin (his rule).

-afil sildenafil, tadalafil-sentan ambrisentan, bosentan, macitentanprost epoprostenol, treprostinil, iloprost

Where it breaks: Selexipag is a prostacyclin-pathway (IP receptor) drug without “prost” in its name.

Pulmonary Arterial Hypertension: Therapeutic AlgorithmAlgorithm · Lecture 42 · slide 28

DecisionTherapy
VasoreactiveHigh-dose oral calcium channel blockers
Not vasoreactive, low / intermediate risk (class II/III)Oral combination (endothelin receptor antagonist + phosphodiesterase-5 inhibitor); early combination beats sequential monotherapy
Not vasoreactive, high risk (class IV or rapid decline)Continuous IV or subcutaneous parenteral prostanoids (epoprostenol)
Refractory to maximal therapy (or pulmonary veno-occlusive disease)Lung transplantation, the only definitive option; IV support as a bridge (slide 29)
Foundations for everyone (slide 27): careful diuresis, oxygen for PaO2 (arterial oxygen pressure) >60 mmHg, supervised rehabilitation (no strict bedrest), annual influenza and pneumococcal vaccines.
Memory aid

Responders get a pill (calcium channel blocker); the rest get Two pills or a Drip: two oral drugs for class II–III, a prostanoid infusion for class IV.

Responder vasoreactive → high-dose oral calcium channel blockerTwo pills low/intermediate → oral combinationDrip high risk → IV or subcutaneous prostanoid

Where it breaks: The slide’s critical rule (no single variable decides) and its intensive-care example are left out.

Cardiogenic vs Noncardiogenic Pulmonary EdemaClassification · Lecture 42 · slides 33, 34, 46

CardiogenicNoncardiogenic
THE GREAT DIVIDE (slide 33)
MechanismIntact capillaries, extreme hydrostatic backupShattered endothelium leaking protein-rich fluid
Wedge pressure>18–20 mmHg≤18 mmHg
Primary defectThe pump is failingThe pipe is leaking
CAUSES (slide 34)
RootsSystolic dysfunction (ischemic, reduced ejection fraction); diastolic dysfunction (stiffening, aging, preserved ejection fraction); valvular lesionsAcute respiratory distress syndrome; sepsis; inhaled toxins
FLASH EDEMA (slide 46)
DriversAcute myocardial infarction, severe hypertension, chronic heart failure decompensationAcute respiratory distress syndrome, high altitude, sepsis, toxins
Cardiac statusEnlargement / dysfunction commonCardiac function typically normal
Slide 38: wedge >18–20 confirms cardiogenic failure. Slide 23’s cut-off for left heart failure is 15.
Memory aid

Pump or Pipe? (His first question: “pipes, pumps, or filter?”) A failing Pump pushes the wedge over 18; a leaking Pipe keeps it at 18 or under.

Pump cardiogenic, wedge >18–20Pipe noncardiogenic (permeability), wedge ≤18

Where it breaks: A wedge above 15 and up to 18 is left-heart by slide 23 but noncardiogenic by slide 33.

The Acute Dyspnea MimicsClassification · Lecture 42 · slide 43

ConditionWhat distinguishes it
Heart failure (cardiogenic edema)Highly elevated BNP (B-type natriuretic peptide); echo abnormalities; Kerley B lines
Pulmonary embolism (the blocked pipe)Clear lungs on chest X-ray; normal BNP initially; S1Q3T3 or right ventricular strain
COPD (chronic obstructive pulmonary disease) exacerbation (the inflamed airway)Wheezing / hyperinflation; hypercapnia; usually normal BNP
Shared by all three: dyspnea, hypoxemia, tachycardia. BNP = B-type natriuretic peptide.
Memory aid

BNP high = Heart; Clear film + S1Q3T3 = Clot; CO2 high + wheeze = COPD.

BNP heart failureClear + S1Q3T3 pulmonary embolismCO2 + wheeze COPD exacerbation

Where it breaks: BNP is normal in both embolism (initially) and COPD; the film and the gas separate those two.

Acute Pulmonary Edema: the LMNOP RescueTreatment steps · Lecture 42 · slide 39

LetterIntervention
L – Loop diuretics (IV)Rapid volume reduction; aggressive diuresis (furosemide, bumetanide, torsemide)
M – MorphineUse with caution. Historically used for venodilation and anxiolysis, but carries respiratory depression risk
N – Nitrates (IV)Immediate preload and afterload reduction via potent venodilation
O – Oxygen / upright positioningBetter ventilation/perfusion matching; gravity drops venous return
P – Positive airway pressureNoninvasive ventilation: alveolar stenting and preload reduction
Flash edema (slide 46): upright with legs dangling; IV furosemide; IV nitrates; CONTINUE oral beta-blockers unless in shock; hold outpatient therapy during acute kidney injury.
His memory aid

LMNOP, “like my toolbox, not a checklist”: use only the tools the patient needs.

L loop diureticsM morphine (caution)N nitratesO oxygen / uprightP positive airway pressure

Where it breaks: Slide 46 says nitrates “rapidly reduce afterload”; slide 39 says preload and afterload. Current guidelines advise against routine morphine.

Heart Failure Stages and the Stage D CliffStaging · Lecture 42 · slide 44

StageMeaningFocus
A & BAt risk and pre-symptomaticPrevention and risk modification
CClinical heart failureQuadruple therapy (angiotensin receptor-neprilysin inhibitor [ARNI], beta-blocker, mineralocorticoid receptor antagonist, sodium-glucose cotransporter-2 [SGLT-2] inhibitor)
DMarked symptoms at rest despite maximal medical therapy; frequent hospitalizationsReferral trigger: heart transplant, mechanical circulatory support (left ventricular assist device), or palliative hospice care
Memory aid

A and B Before symptoms; C = Clinical (the four drugs); D = Done with what drugs can do: refer.

A/B at risk, pre-symptomaticC clinical, quadruple therapyD refractory: transplant, assist device, hospice

Virchow’s TriadClassification · Lecture 42 · slide 49

HypercoagulabilityVenous stasisEndothelial injury
MalignancyProlonged immobilization (>8 hr flights)Recent surgery
Estrogen therapyBed restCentral venous catheters
PregnancyParalysisPacemaker wires
Genetic thrombophiliasHeart failure (New York Heart Association III/IV)Pelvic / lower limb trauma
Sepsis
“Inability to identify a known clinical predisposition should never dissuade an objective evaluation.”
Memory aid

Thick blood, Still blood, Torn vessel: the clot needs one good reason, not fifteen (his: “I just need a couple of good ones”).

Thick hypercoagulability: cancer, estrogen, pregnancy, thrombophilia, sepsisStill stasis: flights, bed rest, paralysis, heart failureTorn endothelial injury: surgery, catheters, pacemaker wires, trauma

Pulmonary Embolism: the Three SyndromesClassification · Lecture 42 · slide 50

SyndromeFeaturesMeans
Isolated dyspneaSudden, minutes to hours; at rest or only with exertion
Pleuritic pain & hemoptysisOften a localized friction rubDistal, pleural-based infarction
Circulatory collapseSyncope, severe hypotension, obstructive shockMassive, proximal occlusion
★ The dyspnea trap: about 25% of proven pulmonary embolisms completely lack dyspnea.
Memory aid

Breath, Blood, Bust: short of breath, coughing blood with a pleuritic pain, or busted circulation.

Breath isolated dyspneaBlood hemoptysis + pleuritic pain = distal infarctionBust collapse = massive proximal clot

Where it breaks: One in four has no “Breath” at all.

Classic Pulmonary Embolism Signs: EKG and Chest FilmClassification · Lecture 42 · slide 51

SignWhat it isMeaning
★ S1Q3T3Deep S in lead I; Q wave and inverted T in lead IIISevere right ventricular strain, not purely embolism; highly specific, low sensitivity
Westermark signFocal peripheral oligemia (decreased vascularity)Classic, infrequent
Hampton’s humpWedge-shaped, pleural-based opacityInfarction
Palla signEnlarged right descending pulmonary arteryClassic, infrequent
Most chest films in embolism are abnormal but nonspecific (atelectasis, effusion).
Memory aid

Westermark = a Wasteland (no vessels); Hampton’s Hump = a Hill-shaped wedge at the pleura; Palla = a Plump Pulmonary artery. S1Q3T3 = “S one, Q three, T three.”

Wasteland Westermark: oligemiaHump Hampton: wedge, infarctionPlump Palla: big right descending artery

Where it breaks: The hook says nothing about sensitivity: S1Q3T3 is specific but not sensitive; the film signs are suggestive but uncommon.

★ Wells Score for Pulmonary EmbolismScore · Lecture 42 · slide 53

PointsCriterion
HIGH WEIGHT
+3.0Clinical signs and symptoms of deep venous thrombosis
+3.0Pulmonary embolism is the #1 diagnosis (more likely than alternatives)
+1.5Heart rate >100 bpm
+1.5Immobilization (>3 days) or surgery in previous 4 weeks
LOWER WEIGHT
+1.5Previous deep venous thrombosis or pulmonary embolism
+1.0Hemoptysis
+1.0Malignancy (on treatment, treated in last 6 months, or palliative)
TOTAL
≤4Unlikely → PERC (Pulmonary Embolism Rule-out Criteria), then D-dimer
>4Likely → straight to CT pulmonary angiography
Memory aid

3 for the Clot you see and the Clinician’s pick; 1.5 for the Heart rate, being Held down (immobile or surgery) and a History of clot; 1 for Hemoptysis and Hostile cells (cancer).

3 + 3 deep venous thrombosis signs; embolism the #1 diagnosis1.5 × 3 heart rate >100; immobilization >3 days or surgery within 4 weeks; previous clot1 + 1 hemoptysis; malignancy4 ≤4 unlikely, >4 likely

Where it breaks: The slide files previous clot under “lower weight” though it scores 1.5, the same as heart rate; learn the points. A total of exactly 4 is unlikely.

★ PERC (Pulmonary Embolism Rule-out Criteria) and D-DimerCriteria · Lecture 42 · slide 54

CriterionCriterion
LAYER 1: THE PERC RULE (all eight true = stop)
Age <50No exogenous estrogen
Heart rate <100No prior venous thromboembolism
O2 (oxygen) saturation >94%No surgery / trauma
No hemoptysisNo unilateral leg swelling
For very low clinical gestalt (<15%). If all true, STOP workup.
LAYER 2: HIGHLY SENSITIVE D-DIMER
Who gets itLow/intermediate probability patients who fail PERC
PerformanceHigh sensitivity, low specificity
NegativeA negative ELISA (enzyme-linked immunosorbent assay) D-dimer safely excludes pulmonary embolism
PositiveProceed to imaging
These tools are designed to rule OUT disease in outpatients; D-dimer has limited utility in inpatients (universally high false-positive rates).
Memory aid

HAD CLOTS: any one of these and PERC fails.

H Hormones (exogenous estrogen)A Age 50 or overD Deep venous thrombosis or pulmonary embolism before (prior venous thromboembolism)C Coughing blood (hemoptysis)L Leg swelling, one sideO O2 saturation ≤94%T Tachycardia (heart rate ≥100)S Surgery or trauma

Where it breaks: PERC is used only after Wells says unlikely; an older patient can never pass it.

CT Pulmonary Angiography vs Ventilation/Perfusion (V/Q) ScanClassification · Lecture 42 · slide 55

CT pulmonary angiographyV/Q scan
Best used forFirst-line imaging for almost all patientsRenal dysfunction, severe contrast allergy, critically ill (portable bedside perfusion scan)
LimitationsIV iodinated contrast; radiation; overdiagnosis of insignificant subsegmental emboliFrequently nondiagnostic with underlying cardiopulmonary disease (chronic obstructive pulmonary disease, severe heart failure)
A completely negative V/Q scan excludes embolism with the same certainty as a negative pulmonary angiogram. Echo (slide 56): poor sensitivity (~50%) for embolism, very high specificity for right ventricular strain: stratification, not diagnosis.
Memory aid

CT for everyone; V/Q when the Kidneys or the contrast allergy say no, or the patient cannot travel.

CT first lineV/Q renal dysfunction, contrast allergy, critically ill

Where it breaks: Chronic obstructive pulmonary disease or severe heart failure points back to CT, because the V/Q scan is often nondiagnostic.

Pulmonary Embolism Diagnostic Algorithm: Decision PointsAlgorithm · Lecture 42 · slide 57

BranchNext step
Wells ≤4 (unlikely)PERC (Pulmonary Embolism Rule-out Criteria): pass → stop; fail → D-dimer: negative → ruled out; positive → CT pulmonary angiography
Wells >4 (likely)Bypass D-dimer: direct to CT pulmonary angiography (or a ventilation/perfusion [V/Q] scan if contrast is contraindicated)
Positive CT or high-probability V/QDiagnosis confirmed → assess hemodynamic stability / right ventricular strain
Memory aid

Wells first, always (his words: “It’s not an either-or. Wells first”). Low road: PERC, then D-dimer, then CT. High road: straight to CT.

Low road ≤4: PERC → D-dimer → CTHigh road >4: CT (or V/Q)

Where it breaks: He wants the decision points, not every box of the chart.

★ Pulmonary Embolism Risk StratificationClassification · Lecture 42 · slide 58

CategoryCriteriaImplication
Low-riskNormotensive, NO right ventricular dysfunction, negative cardiac biomarkersExcellent prognosis, standard anticoagulation
Submassive / intermediateNormotensive (systolic >90) BUT right ventricular dysfunction (echo/CT) or myocardial necrosis (elevated troponin/BNP)High risk for sudden deterioration
Massive / high-riskSustained hypotension (systolic <90 for >15 min), pulselessness, or profound bradycardia; circulatory collapseHigh mortality; immediate advanced intervention
Memory aid

Pressure first, then the heart: low pressure = Massive; normal pressure but a strained or bruised right ventricle = Submassive (“know the one in the middle”); all normal = Low.

Pressure low massivePressure fine, RV (right ventricular) or troponin bad submassiveAll fine low-risk

Where it breaks: Current European guidance splits the middle tier into intermediate-high and intermediate-low; the slide (and the exam) keeps three.

Pulmonary Embolism Treatment: Anticoagulation, Lysis, ExtractionTreatment steps · Lecture 42 · slides 59, 60

SituationTreatment
ANTICOAGULATION (slide 59)
Confirmed (or high suspicion while awaiting imaging)Start anticoagulation immediately
Transient / provoked (recent surgery, trauma, hospitalization, estrogen)Consider stopping after 3 months
Persistent / unprovoked (active malignancy, hypercoagulable state, no risk factor)Indefinite anticoagulation
ADVANCED INTERVENTIONS (slide 60)
Massive (hemodynamically unstable)Thrombolysis (systemic or catheter-directed): “the gold standard”
Massive + absolute contraindication (recent surgery, active bleeding) or right heart clot in transitMechanical thrombectomy or surgical embolectomy
SubmassiveThrombolysis highly controversial (bleeding, intracranial hemorrhage)
Deep venous thrombosis and embolism are treated alike: halt propagation, allow endogenous fibrinolysis. The slides name no drug.
Memory aid

Provoked Pauses at 3 months, Unprovoked is Unending; the Unstable get Lysed, unless they can’t bleed safely or the clot is in transit: then Pull it out.

Pause provoked: 3 monthsUnending unprovoked: indefiniteLyse massivePull thrombectomy / embolectomy when lysis is contraindicated

Where it breaks: Submassive is neither: anticoagulate, and lysis is debated.

Chronic Thromboembolic Pulmonary Hypertension: ScreeningAlgorithm · Lecture 42 · slide 61

Finding at 3 months of anticoagulationNext step
No dyspneaLength of anticoagulation by recurrence risk
Persistent or worsening dyspneaV/Q (ventilation/perfusion) scan
V/Q normalBack to the length decision
V/Q abnormalTransthoracic echo, right heart catheterization, pulmonary angiogram; refer to an expert center; continue anticoagulation
Risk factors: unprovoked embolism, diagnosis delayed >2 weeks, right ventricular dysfunction on the first CT, recurrent embolism. ★ Optimal treatment: surgical (pulmonary thromboendarterectomy).
Memory aid

Still breathless at 3 months? Scan (V/Q), then Send (expert center), then Surgery (thromboendarterectomy).

3 months screen for dyspneaScan V/QSend echo, catheterization, angiogram, expert centerSurgery thromboendarterectomy

Concerning vs Benign NoduleClassification · Lecture 43 · slides 12, 16, 21

Concerning nodules areBenign nodules tend to
Greater than 6 mmSmaller than 6 mm (not concerning unless the patient is high risk)
Located in the upper lobes or hilar structuresSit close to a fissure (usually benign)
Spiculated (spikes or deviations or lobulations in the border)Have well-defined borders (smoothly marginated)
More than 3 nodules; enlarging over timeHave fatty tissue (hamartoma)
Contrast enhanced on CT; cavitated or nonsolidHave calcifications (popcorn = hamartoma; central = healed granuloma)
Patient at high risk of lung cancerMost nodules are benign: granuloma (inflammatory), hamartoma (connective tissue growth)
Slide 16 also says “close to … the pleura” is usually benign, but slide 32’s nodule that involved the pleura was an invasive adenocarcinoma: only the fissure is keyed. Positron emission tomography: low or normal uptake is a good sign (slide 17).
Memory aid

“Magic number is 6”, then BUSTED: Big (over 6 mm), Upper lobe or hilar, Spiculated, Three-plus nodules, Enlarging or Enhancing, Dug-out (cavitated) or nonsolid, plus a high-risk patient.

Big greater than 6 mmUpper upper lobes or hilar structuresSpiculated spiky borderThree-plus more than 3 nodulesEnlarging / Enhancing growing over time; contrast enhanced on CTDug-out cavitated or nonsolid

Where it breaks: The high-risk patient has no letter in BUSTED. The benign column has no letters: smooth, fat, calcium (popcorn), fissure.

Nodule Calcification PatternsClassification · Lecture 43 · slide 16 (picture)

PatternBenign or malignant
DiffuseBenign
CentralBenign
PopcornBenign (hamartoma)
ConcentricBenign
Ground-glass (stippled)Malignant
EccentricMalignant
Memory aid

Benign calcium is Dense, Centered, Popped or in Circles (DCPC); malignant calcium is Grainy or Off-center.

D diffuseC centralP popcorn (hamartoma)C concentric (circles)Grainy ground-glass, stippled: malignantOff-center eccentric: malignant

New Solid Nodule 8–30 mm: the AlgorithmAlgorithm · Lecture 43 · slide 11 (picture)

Clinical probability of malignancyNext step
Very low (< 5%)CT surveillance at 3–6, 9–12, 18–24 months (low-dose, thin sections, noncontrast CT)
Low/moderate (5% to 65%)FDG-PET (fludeoxyglucose positron emission tomography): negative or mild uptake → the same CT surveillance; moderate or intense uptake† → nonsurgical biopsy (transthoracic needle, endoscopic) or video-assisted thoracoscopic surgery with resection
High† (> 65%)Standard stage evaluation (with or without FDG-PET) → no metastases → video-assisted thoracoscopic surgery with resection
Probability by clinical judgment and/or a validated model. † Referral to a pulmonologist, thoracic surgeon, interventional radiologist or oncologist is recommended. He: “Don’t lose sleep over [the probability tables], just know you’re gonna work it up.”
Memory aid

Low → Look (CT surveillance); Middle → Measure the sugar (PET); High → Hand it to surgery (stage, then resection).

Look very low: CT at 3–6, 9–12, 18–24 monthsMeasure low/moderate: FDG-PET, then surveillance or biopsy/resectionHand high: staging, then video-assisted thoracoscopic resection

Where it breaks: Referral (the dagger) applies to both the high branch and the moderate/intense uptake branch.

Lung Cancer Screening (as Slide 18 Gives It)Criteria · Lecture 43 · slide 18 (bold; “30 pack-year” underlined in class)

CriterionSlide 18
WhoHigh-risk adults without symptoms or a known nodule
Age55 to 80
SmokingAt least 30 pack-years
StatusSmokes now, or quit within the last 15 years
TestLow-dose chest CT every year (less radiation than a standard chest CT)
Upside / downsideEarly detection, better prognosis / false positives → unnecessary workup with complications (such as a biopsy)
Medicare only covers 55 to age 77 (slide 18). Current guidelines differ: the 2021 update is 50–80 with 20 pack-years; the slide’s numbers are what is tested. Symptoms mean a diagnostic workup, not screening.
Memory aid

55, 30, 15, 1: age 55 (to 80), 30 pack-years, quit within 15 years, 1 low-dose CT a year.

55 age 55 to 8030 at least 30 pack-years15 smoking now or quit within 15 years1 one low-dose chest CT every year

Where it breaks: The upper age (80) and the no-symptoms rule are outside the numbers.

Fleischner (2017) A: Solid NodulesGuideline · Lecture 43 · slide 19 (picture)

Nodule type<6 mm6–8 mm>8 mm
Single, low riskNo routine follow-upCT at 6–12 months, then consider CT at 18–24 monthsConsider CT at 3 months, PET/CT, or tissue sampling
Single, high riskOptional CT at 12 monthsCT at 6–12 months, then CT at 18–24 monthsConsider CT at 3 months, PET/CT, or tissue sampling
Multiple, low riskNo routine follow-upCT at 3–6 months, then consider CT at 18–24 monthsCT at 3–6 months, then consider CT at 18–24 months
Multiple, high riskOptional CT at 12 monthsCT at 3–6 months, then at 18–24 months (underlined in class)CT at 3–6 months, then at 18–24 months
He said not to memorize it (“they literally will publish the Fleischner table in those reports”), then read these rows aloud. Comments: low-risk nodules <6 mm need no routine follow-up; high-risk patients with suspicious morphology or an upper lobe location may warrant 12-month follow-up; with multiple nodules, use the most suspicious as the guide.
Memory aid

Under 6: low risk Leave it, high risk an Optional look at a year. Over 8: 3 months, PET or tissue. In between: single starts at 6–12, multiple at 3–6, and everyone ends at 18–24.

Leave it <6 mm, low risk: no routine follow-upOptional <6 mm, high risk: optional CT at 12 monthsOver 8 single: CT at 3 months, PET/CT or tissue sampling6–12 / 3–6 first CT for single / multiple 6–8 mm18–24 the second CT

Where it breaks: Multiple nodules over 8 mm follow the 3–6 then 18–24 month rule, not the single-nodule “3 months, PET or tissue”; low-risk rows say “consider” for the second CT.

Fleischner (2017) B: Subsolid NodulesGuideline · Lecture 43 · slide 20 (picture)

Nodule type<6 mm≥6 mm
Single, ground glassNo routine follow-upCT at 6–12 months to confirm persistence, then CT every 2 years until 5 years
Single, part solidNo routine follow-upCT at 3–6 months to confirm persistence; if unchanged and the solid part stays <6 mm, annual CT for 5 years
MultipleCT at 3–6 months; if stable, consider CT at 2 and 4 yearsCT at 3–6 months; then manage by the most suspicious nodule(s)
Persistent part-solid nodules with a solid component ≥6 mm are highly suspicious. Multiple pure ground-glass nodules <6 mm are usually benign. He: “there’s rules, you’re fine”; not on his slide 49 list.
Memory aid

Glass is slow (6–12 months, then every 2 years to 5); a Solid part speeds it up (3–6 months, then yearly to 5); a solid part of 6 mm or more that persists = Suspicious.

Glass ground glass ≥6 mm: CT 6–12 months, then every 2 years until 5 yearsSolid part part solid ≥6 mm: CT 3–6 months, then annual CT for 5 yearsSuspicious persistent solid component ≥6 mm

Where it breaks: Single nodules under 6 mm need no routine follow-up; the multiple row has its own schedule.

Biopsy and Treatment: Fit for Surgery?Algorithm · Lecture 43 · slide 15 (picture)

Fit for surgery?PathEnd point
First: PET-CT for staging (if not already performed)
YesWedge resection with on-table frozen sectionCompletion lobectomy under the same anesthetic
YesImage-guided biopsy → malignancy confirmedLobectomy, or anatomical segmentectomy if unfit for lobectomy
NoImage-guided biopsy if possible and safe → malignancy confirmedSABR (stereotactic ablative radiotherapy), RFA (radiofrequency ablation) or conventional radical radiotherapy
NoBiopsy not possible or not safeStraight to SABR, RFA or radical radiotherapy
A negative biopsy: consider repeat biopsy, or proceed if a false negative is feared. The fit path may also go straight to anatomical segmentectomy if unfit for lobectomy.
Memory aid

Fit = Cut (wedge, lobe, or segment if the lobe is too much); Unfit = Zap (ablate or radiate), biopsy first only if Safe.

Cut resection: wedge then completion lobectomy, lobectomy, or segmentectomy if unfit for lobectomyZap SABR, RFA or conventional radical radiotherapySafe image-guided biopsy only if possible and safe

TNM 8th EditionStaging · Lecture 43 · slide 22 (picture)

CategorySlide 22
PRIMARY TUMOR
T1≤ 3 cm, not involving the main bronchus (1a ≤ 1, 1b >1–2, 1c >2–3 cm)
T2>3 to ≤5 cm, or main bronchus (not carina), visceral pleura, or atelectasis/post-obstructive pneumonitis to the hilum (2a >3–4, 2b >4–5 cm)
T3>5 to ≤7 cm, or chest wall, pericardium, phrenic nerve, or satellite nodules in the same lobe
T4>7 cm, or mediastinum, diaphragm, heart, great vessels, recurrent laryngeal nerve, carina, trachea, esophagus, spine, or a tumor in a different lobe of the same lung
LYMPH NODES
N1Ipsilateral peribronchial and/or hilar and intrapulmonary nodes
N2Ipsilateral mediastinal and/or subcarinal nodes
N3Contralateral mediastinal or hilar; ipsilateral/contralateral scalene/supraclavicular
METASTASIS
M1aContralateral lung, or pleural/pericardial nodule or malignant effusion
M1bSingle extrathoracic metastasis (including a single non-regional node)
M1cMultiple extrathoracic metastases
N2 or N3 automatically moves it to stage 3; all stage 1–3 tumors are M0 (slide 25). Slide 31’s “M1 or 2”: there is no M2.
Memory aid

T climbs 3-5-7 (cm); N climbs Near-Middle-Far (hilar, mediastinal, other side or neck); M is a = still in the chest, b = one outside, c = many outside.

3-5-7 T1 ≤3, T2 >3–5, T3 >5–7, T4 >7 cmNear N1 same-side hilar/peribronchialMiddle N2 same-side mediastinal/subcarinalFar N3 other side, or scalene/supraclaviculara / b / c M1a chest (other lung, pleura, pericardium, effusion), M1b single extrathoracic, M1c multiple

Where it breaks: Invasion of structures (chest wall for T3; mediastinum, heart, carina and others for T4) raises T regardless of size.

Lung Cancer Stages (the Stage Pictures)Staging · Lecture 43 · slides 23–29 (pictures)

StageTumor and nodes, as the pictures state them
1A≤ 3 cm, no nodes
1B>3 to 4 cm, no nodes
2A>4 to 5 cm, no nodes
2B>5 to 7 cm, no nodes (or chest wall, phrenic nerve, heart lining, same-lobe tumor); or ≤5 cm with peribronchial or hilar nodes
3A>7 cm or diaphragm/mediastinal invasion or other-lobe tumor, no nodes; or >5 cm with same-side peribronchial/hilar nodes; or ≤5 cm with mediastinal (subcarinal) nodes
3B>5 cm with same-side mediastinal nodes; or ≤5 cm with other-side nodes or any supraclavicular or scalene node
3C>5 cm with other-side nodes or any supraclavicular or scalene node
4AAny size: the other lung, the pleura or pericardium (nodules or fluid), or one site outside the chest (adrenal)
4BAny size: multiple sites outside the chest (adrenal and bone)
He: “Size of the tumor is badness. Lymph node involvement, badness. Metastasis, worse badness”; crossing to the other lung is badness. Big picture, not every circumstance.
Memory aid

Stage 1 = small, no nodes; 2 = bigger or the first (hilar) nodes; 3 = middle (mediastinal) or far (other side, neck) nodes; 4 = it left: the other lung, the pleura, or outside the chest (A = one site, B = many).

1 ≤4 cm, no nodes (1A ≤3, 1B >3–4)2 >4–7 cm, no nodes, or small with hilar/peribronchial nodes3 N2 or N3 nodes, >5 cm with hilar/peribronchial nodes, or >7 cm / invasion4 M1: 4A one site outside the chest or within the chest; 4B multiple sites

Where it breaks: Stage 3A also holds a tumor over 7 cm (or invading the diaphragm or mediastinum) with no nodes at all.

Central vs Peripheral Lung CancersClassification · Lecture 43 · slide 30 (picture; board pointer, said three times)

Cancer typeMost common location
Small cellCentral, but usually metastatic by the time of diagnosis
Squamous cell carcinomaCentral bronchi; can diagnose via sputum cytology
AdenocarcinomaPeriphery (not amenable to early detection)
Large cell carcinomaPeriphery (not amenable to early detection)
Mixed types exist (adenosquamous, combined small cell). Slide 9: most masses form in or near the hilum, some in the periphery (hard to diagnose).
Memory aid

His own: “Small and squamous are central”: the two S’s Sit in the center; the other two go to the edges.

S Small cell: centralS Squamous cell: centralEdges adenocarcinoma and large cell: periphery

Non-Small Cell Treatment by StageTreatment steps · Lecture 43 · slide 35 (picture)

StageStandard management
1A and BSurgical resection
2A and BSurgical resection
3AChemoradiotherapy, surgical resection in selected patients
3BChemoradiotherapy
4Cisplatin-based chemotherapy (slide: “Ciplatin”); surgical resection only if a solitary metastatic lesion with a resectable primary tumor
Slide 35 text: resection (wedge/segment, lobectomy, pneumonectomy) by size and nodes, “(I–IIIB)”, if the patient can tolerate it; chemotherapy and radiation only as adjuncts or for stage 4, as non-small cell cancers respond poorly. Text and table differ for stage 3: never asked.
Memory aid

1 and 2: Cut. 4: Chemo. 3: the slide argues with itself.

Cut stages 1–2: surgical resectionChemo stage 4: chemotherapy (surgery only for a solitary metastasis with a resectable primary)3 text says resection to 3B; table says chemoradiotherapy (3A, selected surgery)

Small Cell: Stages and Response After Initial TherapyClassification & algorithm · Lecture 43 · slides 41, 43 (picture)

ItemWhat the slides say
CATEGORIES (slide 41)
Limited stageConfined to one area with only local lymph nodes
Extensive stageSpread away from the local area
CombinedDifferent histological types, mixed with non-small cell
COMPLETE OR PARTIAL RESPONSE (slide 43)
Limited stageProphylactic cranial irradiation (PCI) (category 1)
Extensive stageConsider PCI ± thoracic radiotherapy
Brain MRI (magnetic resonance imaging) is preferred over CT; PCI is not recommended with poor performance status or impaired neurocognitive function. Radiation works best in limited stage (slide 41). Follow-up visit schedule: “don’t memorize that.”
Memory aid

Limited gets the Lid (PCI, a cap of radiation on the brain); Extensive only Entertains it (consider PCI ± chest radiation).

Lid limited stage: PCI after a complete or partial responseEntertains extensive stage: consider PCI ± thoracic radiotherapy

Where it breaks: Combined (mixed histology) has no letter; the hook covers the response branch only.

Paraneoplastic Syndromes by SystemClassification · Lecture 43 · slides 46–48

SystemSyndromeLinked type
EndocrineSIADH (syndrome of inappropriate antidiuretic hormone): low sodium and osmolality → confusion, seizures, ataxia, no edemaSmall cell (slide 48)
EndocrineHypercalcemiaSquamous cell (“particularly”)
NeurologicalLambert-Eaton myasthenic syndrome (autoimmune; calcium channels at the nerve ending, no acetylcholine release → leg weakness); cerebellar degeneration or encephalitisNot tied to one type
DermatologicalAcanthosis nigricans or dermatomyositisNot tied to one type
HematologicalListed; no example given—
Carcinoid syndromeSerotonin: flushing, pulmonic and tricuspid valve thickening, wheeze, diarrheaBronchial carcinoid
Slide 46 tags Lambert-Eaton “central” and cerebellar degeneration “peripheral”; slide 47 places Lambert-Eaton at the neuromuscular junction: the tags are never keyed.
Memory aid

Small cell Secretes Sodium-lowering hormone; Squamous Spikes calcium; Carcinoid Causes flushing.

Small → Sodium small cell → SIADH (hyponatremia)Squamous → Spikes calcium squamous → hypercalcemiaCarcinoid → flushing bronchial carcinoid → serotonin (carcinoid syndrome)

Where it breaks: The neurologic and skin syndromes are not tied to a cell type on the slides.

Parietal vs Visceral PleuraClassification · Lecture 44 · slide 3

Parietal pleuraVisceral pleura
WhereLines the thoracic cavity, diaphragm and mediastinumCovers the lungs
Blood supplySystemic circulationPulmonary circulation
Hydrostatic pressureHigherLower
Sensory nervesIntercostal and phrenic nerve fibersNone
Pleurisy is inflammation of the parietal pleura: the layers rub and stimulate its pain fibers (slide 9). The central diaphragm is phrenic territory, so its pain refers to the ipsilateral shoulder or neck (slide 11).
Memory aid

Parietal = Pain and Pressure (and the body’s own Systemic blood); Visceral = Voiceless (no sensory nerves).

Pain parietal: intercostal and phrenic nerve fibersPressure parietal: higher hydrostatic pressure, systemic supplyVoiceless visceral: no sensory innervation, pulmonary supply, lower pressure

Normal Pleural FluidReference values · Lecture 44 · slides 4, 5, 98

FeatureNormal
Volume10 mL (2 teaspoons) in a potential space (slide 4)
AppearanceClear ultrafiltrate of plasma; from parietal capillaries, removed by parietal lymphatics
pH7.60–7.64
ProteinLess than 1–2 g/dL
White blood cellsUnder 1000, mostly macrophages
GlucoseSimilar to plasma
Lactate dehydrogenaseUnder 50% of plasma
Memory aid

Ten clear mL, then count down: 7.6, 1–2, 1000, same, half.

10 mL, clear ultrafiltrate of plasma7.6 pH 7.60–7.641–2 protein under 1–2 g/dL1000 white cells under 1000, mostly macrophagesSame glucose similar to plasmaHalf lactate dehydrogenase under 50% of plasma

Pneumothorax: ClassificationClassification · Lecture 44 · slides 17, 19–20

TypeDefinitionWho / examples
Spontaneous, primaryNo thoracic trauma; no underlying lung abnormalityTall, thin young males, 20–40; male > female; smoking; family history; good reserve (slide 19)
Spontaneous, secondaryNo thoracic trauma; underlying lung abnormalityChronic obstructive pulmonary disease (most common; apical blebs); lung malignancy (may be the first symptom); cystic fibrosis; pneumonia or tuberculosis; sarcoidosis; Marfan syndrome (slide 20)
TraumaticHistory of thoracic traumaBlunt or penetrating trauma; slide 61 adds cardiopulmonary resuscitation and mechanical ventilation
IatrogenicInjury to the pleura from a medical interventionThoracentesis, subclavian vein catheter placement, bronchoscopy, mechanical ventilation
★ Board trap: a tall, thin young man with Marfan syndrome has a secondary pneumothorax (connective tissue disease). Mechanical ventilation is iatrogenic on slide 17 and traumatic on slide 61.
Memory aid

His flat tire: primary “just blew”; secondary “I can explain the flat tire”; iatrogenic is “like trauma, but somebody with a license did it to you.”

Blew primary: no trauma, no lung diseaseExplain secondary: an underlying lung abnormality (including Marfan)Trauma blunt or penetratingLicense iatrogenic: thoracentesis, subclavian line, bronchoscopy, ventilator

Where it breaks: Mechanical ventilation fits both “trauma” and “license” on the slides.

Pneumothorax Size (the 3 cm rule)Cut-off · Lecture 44 · slide 28 ★

Size (American College of Chest Physicians)Apex-to-cupola distance
Small<3 cm
Large≥3 cm
The course measures apex to cupola (a, American); b, the interpleural distance at the hilum, is the British measure. The treatment slides word it as primary “<3 cm” vs “>3 cm” (slides 53–55) and secondary small “≤3 cm” (slide 56); the slide 58 picture uses percent (<20%, >25%). Current guidelines differ: the British Thoracic Society (2023) weighs symptoms over size.
Memory aid

“I like having a nice, easy number”: three centimeters from apex to cupola. Small is small, large is large.

<3 small≥3 largeApex–cupola the American measurement the course uses

Stable or Unstable PneumothoraxCriteria · Lecture 44 · slide 51 ★

Stable = ALL of these (American College of Chest Physicians)Cut-off
Respiratory rate<24 breaths per minute
Heart rate<120 and >60 beats per minute
Blood pressureNormal (no number given)
Room air oxygen saturation>90%
SpeechAble to speak in whole sentences
All other patients are considered unstable. “You can get two sentences, and look at the vitals … So don’t overthink it.”
Memory aid

Really Healthy Breathers Only Speak.

R Respiratory rate <24H Heart rate 60–120B Blood pressure normalO Oxygen saturation >90% on room airS Speaks in whole sentences

Where it breaks: Blood pressure is the one item without a number on the slide.

Spontaneous Pneumothorax: Treatment by PresentationClassification · Lecture 44 · slides 53–57

PresentationTreatment
PRIMARY
Small (<3 cm at apex), asymptomatic or minimal symptoms (slide 53)Observation; analgesia; 100% oxygen by non-rebreather (speeds resorption); repeat film at 6–12 hours; discharge if stable and asymptomatic; repeat film at 24–48 hours
Small with significant dyspnea after analgesia (slide 54)Catheter aspiration; Heimlich valve or chest tube. Chest tube if observation fails (enlarging, respiratory rate >30, saturation <90% on room air) or aspiration fails
Moderate or large (>3 cm), moderate or severe symptoms (slide 55)Chest tube insertion
Recurrent (slide 55)Video-assisted thoracoscopic surgery with pleurodesis
SECONDARY
Small (≤3 cm), asymptomatic or mild (slide 56)Observation if asymptomatic; chest tube for symptoms or persistent air leak; hospitalization
In general: less reserve, more life-threatening (slide 57)Most get a chest tube; thoracoscopic surgery or thoracotomy with bleb stapling and pleural abrasion; chemical pleurodesis via chest tube if surgery is not an option
The slide 58 picture differs: simple aspiration is “first-line” for symptomatic primary pneumothorax; stable patients are observed 4–6 hours; air leaks >72–96 hours go to surgery or a Heimlich valve (slide 60: surgical evaluation after 4 days). Slide 49 lists secondary pneumothorax as a surgical indication while slide 56 observes a small asymptomatic one.
Memory aid

Primary: Watch, Suck, Tube, Fix. Secondary: Admit and Tube.

Watch primary, small, minimal symptoms: observe, analgesia, 100% oxygen, film at 6–12 hoursSuck primary, small but still dyspneic: catheter aspirationTube primary, moderate or large (>3 cm) with symptoms: chest tubeFix primary, recurrent: thoracoscopic surgery with pleurodesisAdmit and Tube secondary: hospitalize; most get a chest tube

Where it breaks: A small asymptomatic secondary pneumothorax is only observed, but in hospital.

Video-Assisted Thoracoscopic Surgery: IndicationsCriteria · Lecture 44 · slides 49–50

Indication (slide 49)Note
Recurrent spontaneous pneumothoraxWith pleurodesis: the best preventive procedure (slide 59)
Bilateral pneumothorax
Failure of tube thoracostomyLung fails to expand, or a persistent air leak
Secondary pneumothoraxHigh recurrence rates and greater consequences of recurrence
Risks: patient discomfort, general anesthesia, greater cost. Open thoracotomy (slide 50) stays for complicated cases: it lets the surgeon find the air leak and free adhesions.
Memory aid

Surgery for the pneumothorax that comes Back, comes in a Pair, Beats the tube, or sits on Sick lungs.

Back recurrentPair bilateralBeats the tube failed tube thoracostomy (no expansion, persistent leak)Sick lungs secondary

Catheter Aspiration: ContraindicationsCriteria · Lecture 44 · slide 39

#Do NOT aspirate in
1Traumatic pneumothorax
2Tension pneumothorax
3Hemodynamic instability
4Underlying pulmonary disease
5Recurrent pneumothorax
6Bilateral pneumothoraces
7Bleeding disorders
Memory aid

Two Trucks Hit Us, Really Badly Bleeding.

T TraumaticT TensionH Hemodynamic instabilityU Underlying lung diseaseR RecurrentB BilateralB Bleeding disorders

Where it breaks: Read the list backward: aspiration suits a first, one-sided, primary pneumothorax in a stable patient.

Procedure SitesSites · Lecture 44 · slides 38, 41, 67–68, 73 ★

ProcedureSite
Needle decompression (needle thoracostomy)Side of the pneumothorax; 2nd intercostal space, over the 3rd rib, midclavicular line (slide 68, “A”)
Catheter aspirationSide of the pneumothorax; 2nd intercostal space, over the 3rd rib, midclavicular line
Chest tube4th or 5th intercostal space, midaxillary line (most common; slide 68, “B”); 2nd–3rd space at the midclavicular line for anterior access (less common, pneumothorax only; slide 73)
★ “For test purposes for now, that would be the right answer”: 2nd space, midclavicular. Slide 68: “You have options; consider patient body habitus and choose wisely!” Current guidelines differ: Advanced Trauma Life Support (10th edition) moves the adult needle site to the 4th or 5th space just anterior to the midaxillary line.
Memory aid

Needles go high and in front; tubes go low and to the side.

High, front needle and aspiration: 2nd intercostal space, midclavicular lineLow, side chest tube: 4th or 5th intercostal space, midaxillary line

Tension Pneumothorax: Recognize and ActCriteria · Lecture 44 · slides 63–66 ★

ItemSlide wording
Mechanism (63)Air enters the pleural space but cannot escape: a one-way valve
Findings (64)Severe ventilatory compromise; mediastinal shift to the contralateral side → ↓ venous return and cardiac output; hypotension, tracheal deviation, neck vein distention; decreased/absent breath sounds
Diagnosis (66)Clinical: time is critical, no time for the X-ray
Treatment (66)Immediate chest tube is ideal; if not readily available, immediate needle decompression, followed by a moderate or large chest tube; admission
The class poll (slide 80): most associated = tracheal deviation away from the collapsed lung (not hypertension, bradycardia or neck subcutaneous emphysema). The slide 58 picture orders it “immediate decompression then chest tube”; slide 66 puts the tube first.
Memory aid

Tension pushes everything AWAY and DOWN: trachea away, blood pressure down, breath sounds gone, neck veins up. Act before the film.

Away trachea deviated away from the collapsed sideDown hypotension (less venous return, less cardiac output)Gone absent breath sounds on that sideUp distended neck veins

Hemothorax: the NumbersCut-off · Lecture 44 · slides 69, 71, 74

FindingMeaning
Pleural fluid hematocrit >50% of blood hematocritHemothorax (slide 74 picture)
Bloody fluid, hematocrit <50%Hemorrhagic effusion
Chest tube output >200 mL/hrThoracotomy (slide 69)
Straight air-fluid line, no meniscusHemopneumothorax (slide 71)
Trauma is the most common cause; the chest tube evacuates and quantifies the bleeding. Retained blood → empyema, fibrothorax, trapped lung. Current guidelines differ: thoracotomy at 1500 mL on insertion or 200 mL/hr for 2–4 hours.
Memory aid

Half and Two Hundred: fluid hematocrit over half the blood’s = hemothorax; over 200 mL an hour out of the tube = open the chest.

Half >50% of the blood hematocrit = hemothorax200 mL/hr from the tube = thoracotomy

Where it breaks: The flat, meniscus-free line of hemopneumothorax is not in the hook.

Pneumothorax vs Pleural Effusion on ExaminationClassification · Lecture 44 · slides 22–23, 87–88, 90, 93, 96

PneumothoraxPleural effusion
InspectionTachypnea; decreased excursion on the affected sideAsymmetrical expansion; trachea away if >1000 mL
Tactile fremitusDecreased/absentDecreased
PercussionHyperresonanceDullness over fluid
Breath soundsDiminished/absent on that sideDiminished/absent; bronchial toward the top
AlsoTachycardiaPleural friction rub
EFFUSION VOLUMES
<300 mL—No physical exam findings (slide 87)
75 mL / 175 mL—Blunts the posterior angle (lateral film) / the lateral angle (frontal film) (slide 90)
10 mL—Smallest amount contrast CT may find (slide 93)
50–100 mL—Removed by diagnostic thoracentesis (slide 96)
Memory aid

Air Booms, water Thuds; both muffle the fremitus and the breath sounds. Volumes: 10 on CT, 75 on the side, 175 on the front, 300 to feel it, 1000 to push the trachea.

Boom pneumothorax: hyperresonanceThud effusion: dullnessBoth decreased fremitus and breath sounds75 / 175 posterior angle (lateral) / lateral angle (frontal)300 / 1000 exam findings start / trachea shifts away

Light’s Criteria: Exudate or TransudateCriteria · Lecture 44 · slides 101, 110, 112 ★

CriterionTransudateExudate
Pleural fluid protein ÷ serum protein≤ 0.5> 0.5
Pleural fluid lactate dehydrogenase ÷ serum lactate dehydrogenase≤ 0.6> 0.6
Pleural fluid lactate dehydrogenase≤ 2/3 upper limit of normal serum> 2/3 upper limit of normal serum
RuleALL three absent (slide 110)AT LEAST ONE (slide 101)
Mechanism (slide 112)↑ hydrostatic or ↓ oncotic pressure (low protein)↑ capillary permeability from inflammation (high protein)
Causes (slide 112)Heart failure, cirrhosis, nephrotic syndromeInfection, malignancy, pulmonary embolism, autoimmune
★ “that makes great test questions.” Pulmonary embolism is exudative on slide 112, transudative on slide 111 and “variable” on slide 83: no question keys its class.
Memory aid

Point Five, Point Six, Two-Thirds: ONE is enough to make it an exudate.

0.5 protein ratio >0.50.6 lactate dehydrogenase ratio >0.62/3 fluid lactate dehydrogenase >2/3 of the serum upper limitOne at least one = exudateNone all absent = transudate

Pleural Fluid ColorClassification · Lecture 44 · slide 98 (picture)

AppearanceUsually means
Clear / strawTransudative effusion
CloudyInflammatory exudative effusion
PurulentEmpyema
BloodyHemothorax or malignancy
Milky whiteChylothorax (elevated triglycerides, slide 105)
BlackRare fungal infection
Appearance alone is not diagnostic; interpret it with the laboratory results and the clinical picture.
Memory aid

Clear is Congestion, Cloudy is Inflamed, Pus is Empyema, Blood is Trauma or Tumor, Milk is the thoracic duct.

Clear transudateCloudy inflammatory exudatePus empyemaBlood hemothorax or malignancyMilk chylothorax

Where it breaks: Black (rare fungal infection) has no word in the hook.

Effusion Causes: Transudate or ExudateClassification · Lecture 44 · slides 81–83, 102–103, 111

Transudate (low protein)Exudate (high protein)
Most commonCongestive heart failure (>90%) (slide 111)Pneumonia; malignancy second (breast, lung, lymphoma 75%) (slide 102); tuberculosis the leading cause worldwide (slide 103)
OthersCirrhosis with ascites; nephrotic syndrome; peritoneal dialysisViral, bacterial, fungal, parasitic infection; connective tissue disease; asbestosis; pancreatic disease; chylothorax
Slide 83 picture: alwaysHeart failure, hepatic hydrothorax, nephrotic syndrome, atelectasis, hypoalbuminemiaParapneumonic effusion, empyema, connective tissue disease, hemothorax, asbestos
Slide 83 picture, variable: malignancy, pulmonary embolism, sarcoidosis, chylothorax, pancreatitis, thyroid disease. Pulmonary embolism moves between columns (transudate slide 111, exudate slide 112, variable slide 83); chylothorax and pancreatic disease are exudates on slide 103 but variable on slide 83. “Malignancy and CHF [congestive heart failure] are gonna be your frequent flyers.”
Memory aid

Pumps, filters, pipes: a failing Pump (heart) or Filter (liver, kidney), or fluid leaking through the diaphragm (cirrhosis, dialysis), makes a transudate; Leaky pipes (pneumonia, cancer, tuberculosis) make an exudate.

Pump congestive heart failure, >90% of transudatesFilter cirrhosis, nephrotic syndromeDiaphragm cirrhosis, peritoneal dialysisLeaky pipes exudate: pneumonia most common, malignancy second, tuberculosis worldwide

Where it breaks: Malignancy, pulmonary embolism, chylothorax and pancreatic disease change columns between slides.

Normal Blood Gas ValuesReference values · Lecture 45 · slides 3, 6, 10

Measurement (slide 6)Arterial bloodVenous blood
pH (range)7.40 (7.35–7.45)7.36 (7.31–7.41)
Partial pressure of oxygen, mm Hg (decreases with age)80–10030–50
Partial pressure of carbon dioxide, mm Hg36–4440–52
Oxygen saturation, % (decreases with age)>9560–85
Bicarbonate, mEq/L22–2622–28
Base difference (deficit/excess)−2 to +2−2 to +2
Slide 3: acidemia = pH <7.35, alkalemia = pH >7.45. Slide 10 gives carbon dioxide as 35–45, slide 6 as 36–44: both are on the slides, so no question should turn on the ends of the range.
Memory aid

Arterial gas = 7.40, 40, 24, each give or take a little: pH ± 0.05, carbon dioxide ± 4 (or 5), bicarbonate ± 2.

7.40 ± 0.05 pH 7.35–7.4540 ± 4 (or 5) carbon dioxide 36–44 (slide 6) or 35–45 (slide 10) mm Hg24 ± 2 bicarbonate 22–26 mEq/L± 2 base difference, arterial and venous alike

Where it breaks: The venous column does not follow the pattern: lower pH, higher carbon dioxide, far lower oxygen.

Anion Gap: Formula, Range & Albumin CorrectionFormula · Lecture 45 · slides 7–8, 26, 44, 47–48 ★

ItemSlide wording
Formula (slides 7, 26)Anion gap = sodium − (bicarbonate + chloride)
Normal (slide 7)6–12 mmol/L (average about 10)
Increased gap (slide 7)Increased unmeasured anions: anionic proteins (albumin), ketoacids, phosphate, lactate; decreased unmeasured cations: calcium, magnesium, potassium; increased albumin
Decreased gap (slide 7)Increased unmeasured cations; addition of abnormal cations: lithium; decreased albumin; hyperviscosity and severe hyperlipidemia can affect the sodium and chloride estimates
Albumin range (slide 8)3.5–5.5 g/dL
Correction (slide 8)The gap must be corrected if albumin is abnormal: add 2.5 mmol/L for each 1 g/dL of serum albumin below 4.5 g/dL
Worked example (slide 8)Albumin 2.5 g/dL (2 below 4.5), uncorrected gap 15 → add 2.5 × 2 = 5 → corrected gap 20
Rule (slide 26)The gap can be abnormal even when sodium, chloride and bicarbonate are normal
Gap cut-offs on different slides: normal 6–12 (slides 7, 47); “Think: anion gap >12” for the raised-gap causes (slide 44); “>20 mEq/L suggests a primary metabolic disorder” (slide 26); decreased <6 (slide 48).
Memory aid

Sodium minus the two big anions, about 10 (6 to 12). Albumin hides acid: for every gram it falls below 4.5, give the gap back 2.5.

Na − (HCO3 + Cl) sodium minus (bicarbonate + chloride)6–12, about 10 normal gap4.5 the albumin you correct to2.5 added per 1 g/dL below 4.515 + 5 = 20 the slide 8 example

Where it breaks: The correction only adds for a LOW albumin; the slide gives no subtraction for a high one.

Identifying the Primary DisorderCriteria · Lecture 45 · slides 10–11, 58–59

DisorderpHPrimary change
Respiratory acidosis↓ (acidemia, <7.35)↑ carbon dioxide
Respiratory alkalosis↑ (alkalemia, >7.45)↓ carbon dioxide
Metabolic acidosis↓ (acidemia)↓ bicarbonate
Metabolic alkalosis↑ (alkalemia)↑ bicarbonate
Slide 10 normals: pH 7.35–7.45, carbon dioxide 35–45, bicarbonate 22–26. Slide 58 (picture): a normal pH = no abnormality or a mixed acid-base disorder. Slide 59 (picture) splits at bicarbonate 24 mM and carbon dioxide 40 mm Hg; respiratory disorders get renal compensation, metabolic disorders get respiratory compensation.
Memory aid

ROME: Respiratory Opposite, Metabolic Equal.

Respiratory Opposite carbon dioxide moves opposite to pH (up in acidosis, down in alkalosis)Metabolic Equal bicarbonate moves the same way as pH (down in acidosis, up in alkalosis)

Where it breaks: ROME is an outside memory aid, not on the slide; it names only the primary change, not the compensation.

Compensation SummaryCriteria · Lecture 45 · slides 23–24, 33–35

Disorder (slide 24)Primary defectCompensatory responseMagnitude of compensation
Respiratory acidosis, acute↑ carbon dioxide↑ bicarbonate↑ bicarbonate 1 mEq/L per 10 mm Hg ↑ carbon dioxide
Respiratory acidosis, chronic↑ carbon dioxide↑ bicarbonate↑ bicarbonate 3.5 mEq/L per 10 mm Hg ↑ carbon dioxide
Respiratory alkalosis, acute↓ carbon dioxide↓ bicarbonate↓ bicarbonate 2 mEq/L per 10 mm Hg ↓ carbon dioxide
Respiratory alkalosis, chronic↓ carbon dioxide↓ bicarbonate↓ bicarbonate 5 mEq/L per 10 mm Hg ↓ carbon dioxide
Metabolic acidosis↓ bicarbonate↓ carbon dioxide↓ carbon dioxide 1.3 mm Hg per 1 mEq/L ↓ bicarbonate
Metabolic alkalosis↑ bicarbonate↑ carbon dioxide↑ carbon dioxide 0.75 mm Hg per 1 mEq/L ↑ bicarbonate
Slide 23: respiratory cause → renal compensation (bicarbonate retained or excreted); renal cause → respiratory compensation (carbon dioxide retained or excreted). Compensation will NOT fully correct the pH; the underlying condition MUST be corrected. Inadequate or excessive compensation points to a mixed disorder; there cannot be more than one primary respiratory disorder. Slide 34: chronic = after 24–48 hours of sustained raised carbon dioxide.
For metabolic acidosis the course works the expected carbon dioxide with the Winter formula (slide 49), not the 1.3 ratio; questions give the ratios when they are needed.
Memory aid

Respiratory: acid 1 then 3.5, alkali 2 then 5 (per 10, acute then chronic). Metabolic: acid 1.3, alkali 0.75 (per 1).

1 acute respiratory acidosis3.5 chronic respiratory acidosis2 acute respiratory alkalosis5 chronic respiratory alkalosis1.3 metabolic acidosis (carbon dioxide falls)0.75 metabolic alkalosis (carbon dioxide rises)

Where it breaks: Respiratory ratios are bicarbonate per 10 mm Hg of carbon dioxide; metabolic ratios flip to carbon dioxide per 1 mEq/L of bicarbonate. Chronic is always the bigger number: the kidneys need 24–48 hours.

Winter Formula: Metabolic Acidosis & a Respiratory DisorderFormula · Lecture 45 · slides 28, 49 ★

Measured carbon dioxideReading (slide 49)
Expected carbon dioxide = 1.5 × bicarbonate + 8, ± 2Winter formula; for anion gap and non-anion gap acidosis alike
= expected (within the ± 2)Metabolic acidosis only
> expectedConcurrent respiratory acidosis
< expectedConcurrent respiratory alkalosis
Slide 28 keys: metabolic acidosis + respiratory alkalosis = high or normal gap acidosis, carbon dioxide below predicted; metabolic acidosis + respiratory acidosis = carbon dioxide above predicted. The slide prints “+ 8 + 2” with the plus-or-minus underline.
Memory aid

“One and a half, plus eight, give or take two.” Lungs breathing too little leave carbon dioxide HIGH (add respiratory acidosis); too much leaves it LOW (add respiratory alkalosis).

1.5 × bicarbonate + 8 ± 2 expected carbon dioxideIn range metabolic acidosis onlyHigh + respiratory acidosisLow + respiratory alkalosis

Where it breaks: Only for a primary metabolic acidosis: the slide gives no Winter-type formula for metabolic alkalosis (use the 0.75 ratio).

Change in Anion Gap vs Change in BicarbonateFormula · Lecture 45 · slides 27, 30, 50 (equation pictures) ★

ComparisonReading (slide 50)
Change in anion gap = calculated gap − normal gap (10 is an accepted value)Slides 27, 50
Change in bicarbonate = the fall from normal bicarbonate (25 is an accepted value)Slides 27, 50
Change in gap = change in bicarbonateMetabolic acidosis only
Change in gap > change in bicarbonateConcurrent metabolic alkalosis; only detectable if the gap is high
Change in gap < change in bicarbonateCheck the change in chloride!
Change in bicarbonate = change in gap + change in chlorideConcurrent increased-gap AND normal-gap metabolic acidosis
Slide 27: the change in gap should equal the change in bicarbonate; differences indicate mixed disorders; then examine the patient again: do the clinical findings support the acid-base analysis? The slides write the bicarbonate change as “lab result − normal”; use the size of the fall from 25.
Memory aid

Every point the gap rises should cost one point of bicarbonate. Bicarbonate fell too LITTLE = something added base (alkalosis). Bicarbonate fell too MUCH = chloride took the rest (a second, normal-gap acidosis).

Gap = bicarbonate pure raised-gap acidosisGap > bicarbonate + metabolic alkalosis (needs a high gap)Gap < bicarbonate check chlorideGap + chloride = bicarbonate + normal-gap acidosis10 / 25 accepted normal gap / bicarbonate

Where it breaks: Only meaningful with a raised gap; a normal-gap acidosis alone has no gap change to compare.

The Six Mixed Disorders: Keys & Slide ExamplesCriteria · Lecture 45 · slides 28–30 ★

Mixed disorderKeySlide example (cause)
METABOLIC + RESPIRATORY (slides 28–29)
Metabolic acidosis — respiratory alkalosisHigh or normal gap metabolic acidosis; carbon dioxide below predictedBicarbonate 14, gap 20, carbon dioxide 24, pH 7.39 (lactic acidosis, sepsis in the intensive care unit)
Metabolic acidosis — respiratory acidosisHigh or normal gap metabolic acidosis; carbon dioxide above predictedBicarbonate 18, gap 20, carbon dioxide 38, pH 7.30 (severe pneumonia, pulmonary edema)
Metabolic alkalosis — respiratory alkalosisCarbon dioxide does not increase as predicted; pH higher than expectedBicarbonate 33, gap 16, carbon dioxide 38, pH 7.55 (liver disease and diuretics)
Metabolic alkalosis — respiratory acidosisCarbon dioxide higher than predicted; pH normalBicarbonate 42, gap 10, carbon dioxide 67, pH 7.42 (chronic obstructive pulmonary disease on diuretics)
METABOLIC + METABOLIC (slide 30)
Metabolic acidosis — metabolic alkalosisOnly detectable with high-gap acidosis; change in gap much greater than change in bicarbonateBicarbonate 25, gap 20, carbon dioxide 40, pH 7.42 (uremia with vomiting)
Metabolic acidosis — metabolic acidosisMixed high-gap + normal-gap acidosis; change in bicarbonate accounted for by the combined change in gap and chlorideBicarbonate 10, gap 15, carbon dioxide 25, pH 7.20 (diarrhea and lactic acidosis, toluene toxicity, treatment of diabetic ketoacidosis)
Each example also gives sodium 140 (135 in the last) and potassium 4.0 (3.5 or 3.0 in the last three). Three of the six have a normal pH (7.39, 7.42, 7.42): a normal pH does not rule out a mixed disorder (slide 58). Only one respiratory disorder at a time (slide 23).
Memory aid

Six marriages, never two lungs: the lung partner shows up in the carbon dioxide (below or above predicted); the second kidney partner shows up in the gap-versus-bicarbonate math.

Low or too-low carbon dioxide + respiratory alkalosis (sepsis, liver disease)High carbon dioxide + respiratory acidosis (pneumonia, chronic obstructive pulmonary disease on diuretics)Gap >> bicarbonate acidosis + alkalosis (uremia with vomiting)Gap + chloride high-gap + normal-gap acidosis (diarrhea and lactic acidosis)

Where it breaks: Respiratory acidosis + respiratory alkalosis is not a pair: only one respiratory disorder at a time.

Increased Anion Gap Metabolic Acidosis: MUDPILESCriteria · Lecture 45 · slides 43–44

LetterCause (slide 44)
MMethanol, metformin
UUremia
DDiabetic / alcoholic / starvation ketoacidosis
PParaldehyde, propylene glycol
IIsoniazid, iron
LLactic acidosis
EEthylene glycol
SSalicylates, starvation
AlsoRenal failure, rhabdomyolysis
Slide 44: think anion gap >12; think metabolic anions, renal failure, toxins. The slide spells “Ethelyne glycol”.
Memory aid

MUDPILES (the slide’s own aid).

M methanol, metforminU uremiaD diabetic, alcoholic, starvation ketoacidosisP paraldehyde, propylene glycolI isoniazid, ironL lactic acidosisE ethylene glycolS salicylates, starvation

Where it breaks: Renal failure and rhabdomyolysis sit outside the letters (“Also”). Four letters carry two causes (M, P, I, S).

The Big 4 Causes of Increased Gap Acidosis (“The Usual Suspects”)Criteria · Lecture 45 · slide 45

GroupSlide items
KetoacidosisDiabetic; alcoholic; starvation
Lactic acidosisPoor tissue perfusion; tissue necrosis; severe anemia; trauma
Renal failureChronic; acute
ToxinsSalicylates; alcohols (methanol, ethylene glycol); 5-oxoproline acidosis from acetaminophen toxicity
Memory aid

The Usual Suspects are KiLleR Toxins.

K Ketoacidosis: diabetic, alcoholic, starvationL Lactic acidosis: perfusion, necrosis, anemia, traumaR Renal failure: acute or chronicToxins salicylates, alcohols, acetaminophen (5-oxoproline)

Where it breaks: Acetaminophen is the toxin not in MUDPILES.

Normal Anion Gap Metabolic Acidosis: USEDCARCriteria · Lecture 45 · slides 43, 46–47

LetterCause (slide 46)
UUreteral diversion
SSaline infusion
EExogenous acid
DDiarrhea
CCarbonic anhydrase inhibitors
AAdrenal insufficiency
RRenal tubular acidosis
AlsoChlorine gas exposure; hyperalimentation (total parenteral nutrition)
SLIDE 47: NORMAL GAP (6–12) BY MECHANISM
Loss of bicarbonateDiarrhea; recovery from diabetic ketoacidosis; pancreatic fluid loss, ileostomy (unadapted); carbonic anhydrase inhibitors
Chloride retentionRenal tubular acidosis; ileal loop bladder
Administration of hydrochloric acid equivalent or ammonium chlorideAdministration of hydrochloric acid equivalent or ammonium chloride; arginine and lysine in parenteral nutrition
Slide 46: think gastrointestinal bicarbonate loss, renal tubular acidosis. Diabetic ketoacidosis itself is a raised-gap cause (slides 44–45); its recovery is normal-gap (slide 47).
Memory aid

USEDCAR (the slide’s own aid); sort it as Leak, Keep, Add: bicarbonate Leaks out, chloride is Kept, acid is Added.

U ureteral diversionS saline infusionE exogenous acidD diarrheaC carbonic anhydrase inhibitorsA adrenal insufficiencyR renal tubular acidosis

Where it breaks: Chlorine gas and hyperalimentation are extras outside the letters.

Decreased Anion GapCut-off · Lecture 45 · slides 7, 48

Cause (slide 48: gap <6)Detail
HypoalbuminemiaDecreased unmeasured anion; the gap must be corrected
Plasma cell dyscrasiasMonoclonal protein (cationic paraprotein accompanied by chloride and bicarbonate)
Bromide intoxication
Slide 7 adds lithium (an abnormal cation) and hyperviscosity or severe hyperlipidemia (sodium and chloride estimates).
Memory aid

Low gap = Little albumin, Lots of paraprotein, Bromide.

Little albumin hypoalbuminemia: correct the gapLots of paraprotein plasma cell dyscrasiasBromide bromide intoxication

Where it breaks: Lithium (slide 7) is not in the hook.

Metabolic Alkalosis: Urine Chloride & CausesCriteria · Lecture 45 · slides 51, 53–54

TypeUrine chloride (slide 51)Causes (slide 53)
Saline-responsiveLower: <25 mEq/LVolume contraction; diuretics (sodium reabsorption, hydrogen ion secretion); vomiting or gastric suction (loss of gastric hydrochloric acid); ingestion of alkaline drugs (sodium bicarbonate); post-hypercapnia
Saline-unresponsive, normotensiveHigher: >40 mEq/LSevere potassium depletion; hypoparathyroidism and hypercalcemia
Saline-unresponsive, hypertensiveHigher: >40 mEq/LPrimary aldosteronism; exogenous alkali; mineralocorticoids; licorice
Slide 51: metabolic alkalosis is not as common as metabolic acidosis. Slide 54: if the cause is unclear, measure urinary chloride to narrow the differential. Slide 53 puts alkaline drugs under saline-responsive and exogenous alkali under hypertensive saline-unresponsive: never decided by group.
Memory aid

Under 25, saline revives; over 40, take the blood pressure. Hypertensive = MEAL.

<25 saline-responsive>40, normal pressure potassium depletion; hypoparathyroidism and hypercalcemiaM MineralocorticoidsE Exogenous alkaliA Aldosteronism (primary)L Licorice

Where it breaks: Urine chloride between 25 and 40 is not assigned on the slide.

Treatment ThresholdsCut-off · Lecture 45 · slides 12, 36, 40

ValueSlide wording
pH <6.7 or >7.6 (slide 12)Unsustainable: may cause cardiac hypocontractility/irritability, seizures, cerebral edema, metabolic disturbances; may warrant therapy to normalize the pH along with treatment of the cause
Carbon dioxide >80 mm Hg and oxygen <40 mm Hg (slide 36)Acute/severe impairment of carbon dioxide excretion with life-threatening hypoxia: adequate ventilation (emergency airway, mechanical ventilator), clear secretions, oxygen
Respiratory alkalosis, pH <7.50 (slide 40)Mild: treatment usually not required
Memory aid

6.7 and 7.6 are mirror digits; 80 in, 40 out is a ventilator; under 7.50 is just breathing fast.

6.7 / 7.6 unsustainable pH80 / 40 carbon dioxide above 80 with oxygen below 40: ventilate7.50 mild respiratory alkalosis: usually no treatment

★ Emphasized: Sleep Physiology

TermWhat you need to know
★ CAN vs CANNOTCapitals on the slide: sleep = unconsciousness from which a person CAN be aroused; coma = one from which a person CANNOT.
★ Two basic typesHer focus: REM vs non-REM, the “two basic overviews”; the separate N1–N3 details and the sleep-wake paragraph are background (know it is positive feedback).
★ Exhausted → little REMVery sleepy: REM episodes short or absent; they lengthen as the person is rested.
★ Non-REMDeep, restful; increased parasympathetic tone; dreams happen but are not remembered (no memory consolidation).
StagesFor this course: three non-REM stages (N1–N3), she said in class; some slides show four.

REM vs Non-REM Sleep

TermWhat you need to know
Non-REM (slow-wave)Deep, extremely restful; increased parasympathetic tone; blood pressure, heart rate, breathing and metabolic rate 10–30% lower; dreams less vivid and often not remembered (not consolidated). Stages N1, N2 (the majority), N3.
REMNot restful; vivid dreams with muscle activity; muscle tone very depressed (atonia except eyes and diaphragm); heart rate and breathing irregular; brain metabolism up to 20% higher; harder to arouse than non-REM, yet spontaneous morning waking happens in REM.
Paradoxical / desynchronizedREM’s EEG looks like wakefulness (paradoxical sleep); neurons fire without synchrony (desynchronized sleep).
Very sleepyREM episodes are short or absent; they lengthen as the person becomes rested.

Why We Sleep & the Sleep-Wake Cycle

TermWhat you need to know
Sleep restrictionOver a few days: worse cognitive and physical performance, productivity and health.
Two effect typesOn the nervous system and on other body systems; the exact functions remain a mystery.
FunctionsNeural maturation; learning and memory; targeted erasure of synapses; cognition; clearing metabolic waste of the awake brain; conserving metabolic energy.
Waking upSleep centers off → mesencephalic and upper pontile reticular activating nuclei released → cortex excited → positive feedback keeps wakefulness going.
Falling asleepHours later the activating neurons fatigue, the feedback loop fades and sleep-promoting centers take over. No definitive explanation exists.

★ Emphasized: Sleep Apnea

TermWhat you need to know
★ AT NIGHTCapitals on the slide: untreated obstructive sleep apnea carries 3–6 times the risk of sudden cardiac death AT NIGHT.
★ ** ASVAsterisks on the slide: adaptive servo-ventilation is not used for all patients, especially in heart failure with reduced ejection fraction.
★ Gold standardsSplit-night and all-night polysomnogram (obstructive apnea); polysomnography with continuous carbon dioxide monitoring (obesity hypoventilation).
★ Diagnosis, simply“As simple as possible”: 5 or more obstructive events per hour plus a symptom, or 15 or more. Home kit = obstructive apnea only; not with cardiopulmonary or neuromuscular disease, and not for central apnea.
★ Education“Patient education is like the most important thing”: CPAP is the most effective but disliked, so counsel. Severe obstructive apnea: oral appliance not effective, use CPAP.
★ Central apnea risk factors“I really want everyone to understand”: heart failure, stroke, opioids, hypoxia, high altitude, CPAP use. Treat the cause first, then CPAP, then ASV (not with poor left ventricular function).
★ OHSDiagnosis of exclusion; male gender is not a risk factor; first line weight loss + BiPAP or CPAP (“first line, first line, first line”).
★ WomenAfter menopause more than before: “the age will help you a lot.”

Obstructive Sleep Apnea

TermWhat you need to know
Who and whyMost common sleep-disordered breathing; rises with age; men > women; post- > premenopausal; upper airway narrowing by soft tissue or structure.
Risk factorsObesity; big tongue, small or set-back jaw; neck 17 in (men) / 16 in (women); big tonsils; age; male; family history; alcohol or sedatives; hypothyroidism.
HistoryDaytime sleepiness, unrefreshing sleep, witnessed apnea, snorting or gasping, loud habitual snoring, morning headache, nocturia, poorly controlled hypertension, poor memory, low libido, night sweats.
ExamObesity, macroglossia, micrognathia, retrognathia, large neck, enlarged tonsils, crowded posterior oropharynx.
TestsThyroid-stimulating hormone if hypothyroid; split-night (2 hours, then CPAP titration) or all-night polysomnogram (mild to moderate at baseline); titration study if the diagnosis is known.
DifferentialCentral sleep apnea, nocturnal dyspnea (heart failure), swallowing disorder, panic attacks, nocturnal asthma, reflux, nocturnal seizures, narcolepsy, periodic limb movements.

Treating Obstructive Sleep Apnea

TermWhat you need to know
Most effectiveContinuous positive airway pressure (CPAP).
Other devicesAutotitrating PAP only without significant comorbidities; positional therapy if supine-only; oral appliance not for severe disease or no teeth; nasal expiratory resistance device.
DrugsModafinil or armodafinil: headache, anxiety, dizziness, nausea, hypersensitivity, many interactions; caution with cardiovascular, hepatic, psychiatric disease; lower doses in the elderly. Nasal steroids for allergic congestion.
SurgeryRadiofrequency ablation (mild to moderate, CPAP-intolerant); palatal implants (mild); maxillomandibular advancement; tracheostomy is a cure; bariatric surgery may help.
Lifestyle and referralDiet and exercise for weight loss; avoid alcohol and sedatives; refer to a sleep physician; counseling.
Older adultsLower mortality (they compensate) but drowsiness and nocturia, which improve with CPAP.

Untreated: Complications & Comorbidities

TermWhat you need to know
HeartArrhythmias, bradycardia, sympathetic tone up, blood pressure variability; ischemic heart disease; heart failure mortality; aortic aneurysm and dissection.
LungsGroup 3 pulmonary hypertension (especially with obesity hypoventilation or daytime hypoxemia).
MetabolicInsulin resistance, type 2 diabetes and its complications; glucose and triglycerides up; worse cardiovascular risk in metabolic syndrome; fatty liver 2–3 times; gout.
OtherStroke; reflux 75–100%; C-reactive protein, cortisol, amyloid up; growth hormone, prolactin down; cytokines up (improve with CPAP).

Central Sleep Apnea

TermWhat you need to know
MechanismBrainstem stops signaling: high carbon dioxide sensitivity → hyperventilation alternating with apnea; no effort (obstructive: effort against a collapsed airway).
Risk factorsHeart failure (Cheyne-Stokes; circulation delay to the carotid chemoreceptors), stroke, opioids, hypoxia, high altitude, CPAP use.
PresentationInsomnia, awakenings, nocturnal dyspnea, nonrestorative sleep, sleepiness; less snoring.
DiagnosisPolysomnography (home not sufficient): repetitive apneas without thoracic-abdominal excursion.
TreatmentTreat the cause (optimize heart failure therapy, reduce opioids, descend) → CPAP → adaptive servo-ventilation if CPAP fails, not in reduced ejection fraction.

Obesity Hypoventilation Syndrome

TermWhat you need to know
DefinitionAwake alveolar hypoventilation (raised awake carbon dioxide) in an obese person, not explained by anything else (Pickwickian syndrome).
Risk factorsCentral obesity, reduced lung function, weak inspiratory muscles, severe obstructive sleep apnea; male sex is NOT a risk factor; 50s and 60s.
Presentation90% have obstructive apnea symptoms (70% severe); 10% sleep hypoventilation (older women, fewer witnessed apneas); many present late with hypercapnic respiratory failure or right heart failure.
ComplicationsPulmonary hypertension, right-sided heart failure, sleepiness, hypertension, heart failure, insulin resistance; refer to a sleep specialist.
PrognosisHigh mortality; cardiovascular disease is the leading cause of death; more hospital and intensive care use; worse with significant awake hypoxemia at diagnosis.

★ Professor Emphasized — Inflammatory Lung Disease

TermWhat you need to know
★ History is the clue“A person showing up at a place with a thing”: occupation, hobbies, exposure, timing. The presentations look alike (exertional dyspnea, dry cough, crackles); the history separates them.
★ Pay attentionThe laboratory clue table (sedimentation rate and angiotensin-converting enzyme = sarcoid, c-ANCA = granulomatosis with polyangiitis, anti-basement membrane = Goodpasture, antinuclear antibody = collagen vascular).
★ Board pointersLupus pernio + dry cough → sarcoid; ferruginous bodies → asbestos; milky lavage → silicosis; hypersensitivity pneumonitis: find the agent, avoid the agent; idiopathic pulmonary fibrosis is the most common.
Not testedDon’t memorize the cause/drug charts; rare subtypes (“desquamative interstitial pneumonia on a test? No”); few Churg-Strauss / Wegener questions; sarcoid immunology slide.
Most timeAcute respiratory distress syndrome (11 of 66 minutes): a feared complication of sepsis, trauma, aspiration and more; the pictures carry AI typos (“Chuck” = shock).

Interstitial Lung Disease: the Common Ground

TermWhat you need to know
What it is200+ disorders of scarring and/or inflammation of the parenchyma (alveoli, ducts, respiratory bronchioles); not malignant, not infectious; stiff, restrictive lungs → shortness of breath.
HowInflammatory cells in alveolar walls → alveolitis → fibroblasts → collagen = fibrosis (permanent).
Two groupsInflammation and fibrosis vs granulomatous; each known or unknown cause. Known: inorganic and organic dusts, fumes, gases. Unknown: sarcoidosis, idiopathic pulmonary fibrosis, connective tissue disease.
Drug causesMethotrexate, amiodarone, nitrofurantoin, bleomycin, chemotherapy, radiation (and the long slide 9 list).
SymptomsProgressive exertional dyspnea or persistent nonproductive cough; hemoptysis, wheeze, chest pain, tachypnea, anorexia; later dyspnea at rest.
ExamSmall lung volumes, bibasilar dry rales (inspiratory crackles), clubbing, right heart failure late; may be normal early.

Idiopathic Interstitial Pneumonia & Pulmonary Fibrosis

TermWhat you need to know
SubtypesIdiopathic pulmonary fibrosis (most common), desquamative, nonspecific, cryptogenic organizing, respiratory bronchiolitis-associated, lymphoid, acute interstitial.
Smoking67–75% of idiopathic and familial fibrosis patients have smoked; smoking is the cause in the majority; cessation is critical.
PictureInsidious dry cough, exertional dyspnea, fatigue; clubbing, bibasilar inspiratory crackles, reduced chest expansion.
TestsRestrictive pattern; CT diffuse patchy fibrosis with pleural-based honeycombing; lower-field markings; biopsy may be needed (lavage, transbronchial, surgical).
TreatmentControversial: nothing improves survival vs no treatment; steroids only for cryptogenic organizing, lymphoid and nonspecific subtypes.

Connective Tissue & Granulomatous Disease

TermWhat you need to know
Connective tissueLupus, rheumatoid arthritis, ankylosing spondylitis, systemic sclerosis, Sjögren, polymyositis-dermatomyositis, scleroderma. Methotrexate treats them and also causes interstitial lung disease.
Hemorrhage syndromesGoodpasture (anti-basement membrane), idiopathic pulmonary hemosiderosis, isolated pulmonary capillaritis.
GranulomatousSarcoidosis; granulomatosis with polyangiitis (c-ANCA); Churg-Strauss; hypersensitivity pneumonitis.

Sarcoidosis

TermWhat you need to know
WhoMulti-organ, noncaseating granulomas, lungs and lymphatics most; North American Black and Northern European white people; women; third and fourth decades.
PictureCough, insidious dyspnea, chest discomfort, malaise, fever, weight loss, nontender lymphadenopathy; erythema nodosum (painful rashes, lower legs), parotid enlargement, lupus pernio (painful skin sores, face), hepatosplenomegaly.
TestsFilm: symmetric bilateral hilar and right paratracheal adenopathy; angiotensin-converting enzyme up in 40–80%, hypercalcemia (5%), hypercalciuria, eosinophilia, high sedimentation rate; biopsy confirms (transbronchial or fine-needle node).
TreatmentCorticosteroids (90% respond) for the listed indications; methotrexate, azathioprine, infliximab if intolerant or refractory.
Follow-upYearly: exam, pulmonary function, chest film, electrocardiogram, chemistry, eye exam.

Hypersensitivity Pneumonitis

TermWhat you need to know
WhatNon-atopic, non-asthmatic; inhaled organic dust: moldy hay (farmer’s lung), bird excreta and feathers (bird fancier’s), cheese maker’s lung, moldy sugarcane, infested grain.
PictureMalaise, chills, fever, cough, dyspnea, nausea hours after exposure; may mimic paroxysmal nocturnal dyspnea (worse after work at home); crackles, tachypnea, tachycardia, cyanosis.
TestsSerum antibodies to the agent = definitive; white count up with left shift; hypoxia; restrictive; small nodules sparing apices and bases; biopsy if subacute or chronic; noncaseating granulomas.
TreatmentIdentify and avoid the agent; steroids if severe; supportive; transplant. Reversible if caught early.

Acute Respiratory Distress Syndrome

TermWhat you need to know
CausesDirect: aspiration, diffuse pneumonia, contusion, toxic gas, near-drowning, emboli. Systemic: sepsis (about a third of cases), pancreatitis, shock, trauma, overdoses, transfusions, amiodarone, nitrofurantoin.
PictureDyspnea 12–48 hours after the insult; hypoxemia refractory to oxygen; tachypnea, retractions, crackles; multiorgan failure.
ImagingBilateral infiltrates becoming confluent; air bronchograms (about 80%); normal heart size, few effusions; echocardiogram excludes cardiogenic edema (cardiomegaly, batwing opacities).
ManagementTreat the cause; low tidal volume; positive end-expiratory pressure for arterial oxygen above 60; early prone positioning (moderate to severe); conservative fluids; transfuse at 7 g/dL; steroids within 14 days (conditional); avoid oscillatory ventilation and routine pulmonary artery catheters; neuromuscular blockade controversial; ECMO (extracorporeal membrane oxygenation) salvage.
PrognosisMortality about 30% (20% trauma to 80% end-stage liver disease); lung function recovers over 6–12 months; residual diffusion deficits, weakness, fatigue.

★ Professor Emphasized — Pulmonary Vascular Disease

TermWhat you need to know
★ The one thing“If you walk away with nothing else”: about 25% of proven pulmonary embolisms have no dyspnea. Don’t rely on shortness of breath.
★ Board questionsS1Q3T3 = right ventricular strain (highly specific, low sensitivity); Westermark, Hampton’s hump, Palla: “great for board questions,” rarely seen.
★ Fair gameWells and PERC: “easy math.” Wells first; ≤4 unlikely → PERC (every item negative) → D-dimer; >4 → straight to CT.
★ Know the middleEmbolism submassive = normal pressure + right ventricular strain or raised troponin/BNP (“what you’re gonna get on the PANCE”). Pulmonary hypertension: right ventricular failure signs = automatically high risk.
★ You should knowPhosphodiesterase-5 inhibitors (sildenafil, tadalafil: “your AFILs”); the rest by class (“PROST in the name”).
★ Cor pulmonaleCOPD (chronic obstructive pulmonary disease) is the absolute leading cause; alveolar hypoxia is the most important driver; septal flattening = D-shaped left ventricle.
★ The standardsRight heart catheterization confirms pulmonary hypertension; CT pulmonary angiography for embolism (ventilation/perfusion [V/Q] scan if not); echo in embolism is “for stratification,” not diagnosis; CTEPH (chronic thromboembolic pulmonary hypertension) is treated surgically.
Not testedSlide 20 charts; wedge detail (slide 24); the slide 28 intensive-care rule; slide 44 (“don’t go crazy”); whole flowcharts; off-slide asides (sinus tachycardia, drug names).

Cor Pulmonale

TermWhat you need to know
DefinitionRight ventricular enlargement, hypertrophy or dilation caused exclusively by a primary lung or pulmonary vascular disorder; raised mean pulmonary artery pressure with a normal wedge. Left heart failure (Group 2) is not cor pulmonale.
CausesCOPD (>50% of patients), interstitial lung disease, sleep-disordered breathing; acute embolism, pulmonary arterial hypertension (Group 1), CTEPH (Group 4).
MechanismGlobal alveolar hypoxia + hypercapnia (“Blue Bloater”) → diffuse vasoconstriction → resistance ↑ → afterload ↑; vascular bed loss; polycythemia raises viscosity.
Acute crashSeptum bows into the left ventricle → output plummets → shock; distended neck veins, tricuspid murmur, tachycardia, pallor.
Chronic examRight ventricular heave, loud P2, tricuspid murmur; tender hepatomegaly, ascites, dependent pitting edema.
TestsEKG: peaked P (right atrium), tall R in V1, right axis deviation (chronic); abnormal in 70% of acute embolism. Echo: systolic septal flattening = D-shape, pulmonary artery systolic pressure. Film: flat diaphragms, big central arteries; fields may look clear.
TreatTreat the lung disease; oxygen is a drug (Group 3); bronchodilators, infection control; lysis + anticoagulation in acute embolism. Careful diuresis: the right ventricle needs preload; watch for hypokalemia.

Pulmonary Hypertension

TermWhat you need to know
AxiomThe most common cause of right ventricular failure overall is left ventricular failure.
PathwayHypertrophy → dilation and failure → septal bowing into the left ventricle → exertional syncope despite normal left ventricular contractility.
ExamLarge a or v waves; right ventricular heave; accentuated P2; right-sided S3; hepatojugular reflux >1 cm; edema to hips/sacrum; cool extremities. S3 = “floppy,” S4 = “stiff” (his).
TestsEcho = most useful initial test; V/Q (ventilation/perfusion) = essential to exclude CTEPH (chronic thromboembolic pulmonary hypertension) (mismatch → thromboendarterectomy); right heart catheterization confirms.
FoundationsCareful diuresis; PaO2 (arterial oxygen pressure) >60 mmHg (sleep, exertion); avoid strict bedrest, supervised aerobic rehabilitation; annual influenza and pneumococcal vaccines.
End stageEarly palliative care and advance directives (sudden death may come first); 6% survival at 90 days after CPR; lung transplantation = only definitive option.

Pulmonary Edema

TermWhat you need to know
StarlingOutward hydrostatic pressure (the engine of cardiogenic edema) beats inward oncotic pressure, or the membrane shatters.
BedsidePink frothy sputum (late), bilateral rales/crackles and wheeze, S3, dyspnea, diaphoresis, tripoding.
TestsBNP (B-type natriuretic peptide): substantial rise = cardiogenic; transthoracic echo: structure, ejection fraction, valves; catheter when the cause is uncertain (wedge >18–20 = cardiogenic).
FilmBatwing (perihilar edema), peribronchial cuffing, Kerley B (interlobular septa), bilateral effusions; flash edema: butterfly pattern, vascular blurring.
Flash edemaTriggers: acute MI, ischemia, severe hypertension; nonadherence, salt, rapid arrhythmias. Upright with legs dangling; IV furosemide; IV nitrates; continue beta-blockers unless shock; hold outpatient therapy in acute kidney injury; cautious morphine.
ChronicQuadruple therapy (angiotensin receptor-neprilysin inhibitor [ARNI], beta-blocker, mineralocorticoid receptor antagonist, sodium-glucose cotransporter-2 [SGLT-2] inhibitor) = greatest mortality reduction in reduced ejection fraction.

Pulmonary Embolism

TermWhat you need to know
ContinuumDeep venous thrombosis and embolism are one disease: asymptomatic to collapse and death.
PresentationIsolated dyspnea; pleuritic pain + hemoptysis (infarction, friction rub); collapse (obstructive shock = massive). 25% no dyspnea.
D-dimerHigh sensitivity, low specificity; negative ELISA (enzyme-linked immunosorbent assay) excludes; outpatients only (inpatient false positives).
EchoMassive embolism → septum bows into the left ventricle → output crashes. Poor sensitivity (~50%), very high specificity for right ventricular strain: risk stratification, not diagnosis.
TreatmentAnticoagulate all; lyse the unstable; thrombectomy/embolectomy when lysis is contraindicated or a clot is in transit; screen for CTEPH (chronic thromboembolic pulmonary hypertension) at 3 months.

Adults vs the Elderly; Referral

TermWhat you need to know
Adult (reduced ejection fraction)Ischemia-driven pump loss; higher reserve; aggressive diuresis generally well tolerated.
Elderly (preserved ejection fraction)Age-related stiffening, high end-diastolic pressure; extreme preload sensitivity, narrow margin; gentle, precise diuresis (over = hypotension, under = recurrent flooding).
Age and PERC (Pulmonary Embolism Rule-out Criteria)PERC needs age <50: an older patient cannot pass it.
ReferralStage D heart failure → transplant, assist device or hospice; refractory pulmonary hypertension → lung transplant; abnormal V/Q (ventilation/perfusion) at 3 months → expert center (thromboendarterectomy).

★ Professor Emphasized — Pulmonary Nodules & Neoplasms

TermWhat you need to know
★ His exam listSlide 49 “Things to Know”: screening, benign vs worrying nodule, staging and its treatment, central vs peripheral, recognize squamous and small cell, radiotherapy, paraneoplastic signs. “Big picture, guys.”
★ Board pointer (3x)“Small and squamous are central”; adenocarcinoma and large cell peripheral.
★ Magic number 6Over 6 mm = suspicious, especially upper lobe or hilar and spiculated (“spiky”; “you don’t usually see a lot of benign stuff that’s described as spiculated”).
★ Test-question pointerLarge cell metastasizes to the small intestine and bowel: “unique to a thing makes a great test question.”
★ SquamousStrongest smoking link, central from a bronchus, cavitation, cough/wheeze/hemoptysis like a COPD (chronic obstructive pulmonary disease) flare that never settles; sputum can catch it; hypercalcemia.
★ Small cellDoes better with chemotherapy and radiation (best in limited stage); prophylactic cranial irradiation; SIADH: confusion and seizures in the emergency department → “oh, that’s lung cancer.”
Not to memorizeFleischner tables (reports print them), probability tables, staging charts in detail, node stations, genes, marker-to-drug choices, small cell follow-up schedule. Primary care: screen, figure out risk, refer.
Most timeEpidemiology and spread 7.5 min; incidental nodules and symptoms 7.1; staging 5.25 (of about 55 minutes taught).

Pulmonary Nodule: Finding and Working It Up

TermWhat you need to know
Found howIncidentally on a chest X-ray or CT done for another reason; size first: under 6 mm not concerning unless high risk; a solitary nodule on chest X-ray = coin lesion.
UsuallyBenign: granuloma (inflammatory) or hamartoma (connective tissue growth); high-risk patients are worked up to exclude malignancy.
WorkupChest X-ray “not a good tool”; CT with contrast of chest and upper abdomen, then biopsy (bronchoscopy, transthoracic, thoracoscopy by location; can be CT guided); PET; genetic testing.
LabsComplete blood count with differential, metabolic panel with calcium, alkaline phosphatase, pulmonary function tests; sputum cytology (not sensitive).
PETRadioactive sugar (fludeoxyglucose): high uptake suggests malignancy; low or normal uptake is a good sign; inflammation can also take it up.
Benign CTSmooth nodule with fat and calcification = hamartoma; central calcification = healed granuloma; next to the minor fissure = scar or lymphoid tissue.

Lung Cancer: Who, Why, How It Spreads

TermWhat you need to know
Deaths>30% of cancer deaths in men (highest of all cancers in men), >25% in women; five-year survival 17–18%.
Smoking85–90% of cases (second-hand smoke 20%); packs per day × years compound it (5x, 10x, 20x).
Other risksRadiation and radon, air pollution, chemical toxins, tuberculosis or HIV (human immunodeficiency virus) infection, genetics, diet, alcohol.
AgeMost over 50; about 4% under 40 (keep it on the differential).
TypesSmall cell (oat cell, 15–20%) and non-small cell: adenocarcinoma (most common), squamous (20–30%), large cell (9–10%); rare: carcinoid, bronchial gland, sarcomatoid, Pancoast.
SpreadOncogenes on, tumor suppressors off; most masses in or near the hilum, some peripheral (hard to find); to regional nodes, then liver, brain, bone; hyperplasia → dysplasia → in situ → invasive → metastases.

Presentation and Metastatic Signs

TermWhat you need to know
Work up ifPersistent cough, hemoptysis, dysphagia, wheeze or shortness of breath, weight loss, fever or fatigue, bone or chest pain, endocrine disorders.
Why deadlyNo symptoms until advanced or metastatic; in COPD it can pass for an exacerbation.
BrainHeadache, vision change, nausea, vomiting, syncope, seizures; papilledema (raised intracranial pressure); cranial nerve signs (midbrain/pons).
LiverDull right upper quadrant ache, firm hepatomegaly, poor appetite, jaundice, hepatic failure.
BonePain; fractures without falls (a cough can fracture the spine); spinal cord compression.
AdrenalAdrenal insufficiency (slide heading “Kidneys”): fatigue, weight loss, dizziness, hypotension, low sodium with high potassium (not SIADH).

Adenocarcinoma, Large Cell, Squamous Cell

TermWhat you need to know
AdenocarcinomaMost common; periphery, mid-lung; peripheral scars; smoking not always; from type II pneumocytes (atypical adenomatous hyperplasia, in situ, lepidic, invasive); mucicarmine stain = mucin; spiculated peripheral nodule; 2/3 present advanced.
Large cellDiagnosis of exclusion; anaplastic, pleomorphic, cells 3x larger; periphery; necrosis and hemorrhage; large cavitated peripheral mass; mets to small intestine and bowel; no standard treatment; mucicarmine negative.
Squamous cell2nd most common (20–30%); strongest smoking link; central, from a bronchus; obstruction → cough, wheeze, hemoptysis, atelectasis, pneumonia; local invasion → dysphagia, voice change; sputum cytology; hypercalcemia; cavitated spiculated lesion.
Non-small cell treatmentResection (wedge, segment, lobectomy, pneumonectomy) if the patient can tolerate it; chemotherapy/radiation as adjuncts or stage 4; markers (TP53, EGFR, KRAS, ALK) let the oncologist tailor therapy; checkpoint inhibitors (“-mab”, PD-1 pathway) keep T cells on.

Small Cell Carcinoma & Radiotherapy

TermWhat you need to know
PictureOat cell; central, infiltrates the mucosa; insidious: >70% metastatic (liver, bone, brain) before detection; high cavitation once large; chromosome 3 short-arm lesion.
ParaneoplasticNeuroendocrine (APUD, amine precursor uptake and decarboxylation) cells secreting polypeptide hormones → SIADH.
HistologyFragile, crushed at biopsy; small cells, no nucleoli, high nuclear-to-cytoplasm ratio.
TreatmentResponds better to chemotherapy and radiation than non-small cell; radiation best in limited stage; prophylactic cranial irradiation; adjunct immunotherapy (nivolumab, atezolizumab).
Radiation effectsAcute: skin erythema and hyperpigmentation (ulceration risk), inflammation, hair loss, little nausea. Chronic: pulmonary fibrosis, coronary and valve disease, cardiomyopathy, lymphedema (think axillary), neuropathy.

Paraneoplastic Syndromes & Carcinoid

TermWhat you need to know
WhatHormonal or cytokine effects of tumor tissue (primary or metastasis): endocrine, neurological, dermatological, hematological.
SIADH (small cell)Excess antidiuretic hormone (vasopressin) → water retention → low sodium, low osmolality → confusion, seizures, ataxia; no edema (insidious).
HypercalcemiaParticularly squamous cell; calcium is in the lab workup.
Lambert-EatonAutoimmune attack on calcium channels at nerve endings → less acetylcholine → progressive leg weakness; neuromuscular junction; rare (3000 a year).
Carcinoid syndromeMainly from a bronchial carcinoid; serotonin: flushing, apparent cyanosis, pulmonic and tricuspid valve thickening, wheeze, hepatomegaly, diarrhea, cramps, retroperitoneal and pelvic fibrosis.

Adults, Older Adults & Referral

TermWhat you need to know
Older adultsScreen 55–80 (30 pack-years, smoking or quit within 15 years); most cancers over 50; unfit for lobectomy → segmentectomy; unfit for surgery → radiotherapy or ablation.
Brain radiationProphylactic cranial irradiation not recommended with poor performance status or impaired neurocognitive function.
ReferralHigh probability or moderate/intense PET uptake → pulmonologist, thoracic surgeon, interventional radiologist or oncologist; primary care screens, judges risk and refers.
EducationSmoking cessation (risk compounds with dose); screening false positives; symptoms come late.

★ Professor Emphasized — Pleural Disorders

TermWhat you need to know
★ Light’s criteria“that makes great test questions”: protein ratio >0.5, lactate dehydrogenase ratio >0.6, fluid lactate dehydrogenase >2/3 of the serum upper limit; one is enough for an exudate.
★ TensionRecognize it at the bedside and act (“I don’t have to prove it”): hypotension, trachea away, neck veins distended, absent breath sounds. The poll answer: tracheal deviation away from the collapsed lung.
★ Needle site“For test purposes for now, that would be the right answer”: 2nd intercostal space, over the 3rd rib, midclavicular line (typical site, not only site).
★ Board trapTall, thin 22-year-old with Marfan syndrome = secondary spontaneous pneumothorax.
★ Numbers he likes3 cm apex to cupola (“a nice, easy number”); the stability list (“don’t overthink it”). “Don’t confuse gold standard [CT] with best initial test [upright chest film].”
★ Education“this may be a question you get”: recurrence approaches 50% within 3 years; stop smoking; thoracoscopic surgery with pleurodesis is the best prevention.
★ Effusions“Malignancy and CHF [congestive heart failure] are gonna be your frequent flyers”; heart failure is about 90% of transudates.
Lighter touchCauses of pleurisy; procedure details and chest tube sizes (“know what the toolbox looks like”); the slide 97 laboratory thresholds (“Don’t go crazy about this”); flow charts.
Most timePneumothorax took about 60% of the lecture (procedures, treatment and education, imaging and size, types, traumatic and tension).

The Pleura & Pleurisy

TermWhat you need to know
PressureIntrapleural pressure is always negative (about −4 mm Hg: 756 vs 760); the chest wall pulls out, the lung recoils in, and the suction keeps the lung inflated.
PleurisyInflammation of the parietal pleura; a symptom, not a diagnosis. Causes: idiopathic, trauma, infection, lupus or rheumatoid arthritis, pneumothorax, pulmonary embolism, malignancy, drugs (methotrexate, amiodarone, hydralazine).
PictureWell-localized sharp pain worse with breathing, coughing, movement, sneezing; central diaphragm → ipsilateral shoulder or neck pain.
ExamTachypnea, limited expansion; pleural friction rub (grating, both phases) that disappears when the breath is held (a pericardial rub does not).
Rule out firstMyocardial infarction, pericarditis, aortic dissection, pneumonia, pneumothorax, pulmonary embolism (“big scary things”); then rib or vertebral fracture, costochondritis, zoster.
TreatThe underlying condition + nonsteroidal anti-inflammatory drugs.

Spontaneous Pneumothorax: Picture

TermWhat you need to know
CauseRupture of apical blebs (<1 cm, in the visceral pleura) or bullae (>1 cm).
HistoryOften at rest; acute dyspnea + ipsilateral pleuritic chest pain (severe, stabbing, worse with deep breaths); may be asymptomatic if small; cough less common.
ExamTachypnea, tachycardia, decreased excursion, decreased/absent fremitus, hyperresonance, diminished/absent breath and voice sounds on that side.
SecondarySame picture but worse (less reserve); infection adds cough, fever, chills.
DifferentialMyocardial infarction, pulmonary embolism, aortic dissection, pericarditis, pleurisy, muscle strain, costochondritis.

Pneumothorax Imaging

TermWhat you need to know
Upright chest filmInitial test: the visceral pleural line with no markings beyond it.
Supine filmDeep sulcus sign: a dark, deep costophrenic angle from air collecting laterally.
UltrasoundBedside, for the unstable patient: absent lung sliding; does not size it.
CTGold standard for presence, size and location; finds blebs and bullae; impractical when time is critical.
Tension on a filmMediastinal shift, diaphragm depression: “You should never ever see this before recognizing it.”

The Procedures Toolbox

TermWhat you need to know
GoalsEvacuate the space; close the leak; prevent recurrence.
Catheter aspirationLarge-gauge needle, catheter, 3-way stopcock, syringe; 2nd space midclavicular; over 2 liters out → consider a persistent air leak; film afterward.
Heimlich valveOne-way flutter valve on a chest tube; small, portable, lets the patient walk.
Chest tubeDrains air or fluid; pneumothorax or effusion; 4th or 5th space midaxillary.
PleurodesisInflames the pleura so the layers stick (no space for air or fluid): mechanical (surgical abrasion) or chemical (talc or drugs via chest tube or thoracoscope). Most common use: malignant effusion.
SurgeryThoracoscopic surgery has largely replaced open thoracotomy; thoracotomy stays for complicated cases.

After the Pneumothorax: Education

TermWhat you need to know
RecurrenceApproaches 50% within 3 years (slide 59); one-third of primary cases within 1–2 years, >60% after a second episode, >75% on the same side (slide 60).
LifestyleStop smoking (up to 100-fold risk); delay air travel 7–14 days after a film confirms resolution; avoid scuba diving; hold positive pressure during an active leak.
ReferSurgical evaluation for an air leak >4 days; pilots and divers early; genetics for a family history.

Traumatic & Tension Pneumothorax

TermWhat you need to know
TraumaticGunshot, stab, blunt trauma with rib fractures, cardiopulmonary resuscitation, mechanical ventilation: ask “Have you had any trauma?”
Closed vs openClosed: no wound, air from the lung. Open: chest-wall wound lets air in on inhalation (sucking chest wound).
TensionOne-way valve; hypotension, trachea away, neck veins up, breath sounds gone; clinical diagnosis.
ActChest tube now; if none, needle at the 2nd space midclavicular, then a chest tube. “This needle buys moments.” Never aspirate.

Hemothorax

TermWhat you need to know
CauseTrauma most common (heart, great vessels, lung, intercostal or internal thoracic arteries); neoplasms.
DefineFluid hematocrit >50% of the blood’s; strictly exudative. Hemopneumothorax: straight line, no meniscus.
TreatChest tube to evacuate and quantify; >200 mL/hr → thoracotomy.
RiskRetained blood → empyema, fibrothorax, trapped lung. An effusion that grows on anticoagulation needs a tap.

Pneumomediastinum

TermWhat you need to know
CauseAlveoli rupture next to the mediastinum (high pressure), esophageal perforation, or air tracking from neck or abdomen; after violent coughing, vomiting, inhaled drugs (Valsalva).
PicturePleuritic chest or neck pain, sore throat, dyspnea, cough.
ExamSubcutaneous emphysema in the neck; Hamman crunch: substernal crackling with each heartbeat (“snap, crackle, and pop”).
TreatAirway; treat the cause; conservative (oxygen, rest, analgesics); severe → emergent cardiothoracic surgery.

Pleural Effusion: Picture

TermWhat you need to know
MechanismsAltered permeability (inflammation, malignancy, pulmonary embolism); ↓ oncotic pressure (nephrotic syndrome, cirrhosis); ↑ hydrostatic pressure (heart failure); blocked lymphatics (malignancy, trauma); peritoneal fluid across the diaphragm (cirrhosis, dialysis).
Who>1.5 million a year in the United States; heart failure the leading cause; malignant effusions can come years after a cancer diagnosis; asbestos exposure.
SymptomsNone if small; dyspnea, dry cough, pleuritic pain referred to the shoulder or upper abdomen.
CluesEdema, orthopnea, paroxysmal nocturnal dyspnea → heart failure; fever, purulent sputum → pneumonia; hemoptysis → malignancy; night sweats, weight loss → tuberculosis.

Effusion Workup

TermWhat you need to know
ImagingUpright film (75 mL posterior, 175 mL lateral angle); decubitus film (effusion side down) now replaced by ultrasound, which also guides the tap; contrast CT finds 10 mL and associated disease.
LoculationFluid trapped in compartments by adhesions between the pleurae (empyema).
ThoracentesisDiagnostic (50–100 mL) for a new effusion with no clinical cause; therapeutic relieves symptoms.
Send forProtein, lactate dehydrogenase, white count with differential, Gram stain, cytology (malignancy), culture; then Light’s criteria.

Exudates: Chylothorax & Empyema

TermWhat you need to know
ChylothoraxThoracic duct disruption (trauma, thoracic surgery most common; mediastinal tumors) → milky fluid, high triglycerides. Treat: chest tube or intermittent taps without over-draining (nutrition), octreotide, cut long-chain triglycerides.
EmpyemaPus in the pleural space; pneumonia with a parapneumonic effusion is the usual precursor; suspect it when pneumonia does not resolve. Treat: drainage + antibiotics promptly.

Transudates & Treating an Effusion

TermWhat you need to know
TransudatesCongestive heart failure >90%; cirrhosis with ascites, nephrotic syndrome, peritoneal dialysis.
TreatTreat the underlying disorder (diuretics first for heart failure); therapeutic thoracentesis; chest tube.
Recurrent malignantPleurodesis = palliative (lung, breast, ovarian); indwelling tunneled catheter placed as an outpatient and drained at home for short prognoses or a non-expandable lung.

Pleurodynia (Bornholm Disease)

TermWhat you need to know
WhatViral myalgia of the striated intercostal muscles, usually coxsackie B virus; after an upper respiratory or gastrointestinal infection; summer.
PictureFever with paroxysms of knife-like pain lasting 15–30 minutes: pleuritic in adults, abdominal in children; splinting, tender muscles.
TestsElevated creatine kinase; chest film usually normal (rules out other causes).
TreatSupportive: NSAIDs (nonsteroidal anti-inflammatory drugs) and heat. Slide 118: resolves in 2–4 days, may recur; the slide 119 picture says 4–6 days (not keyed).

★ Professor Emphasized — Acid-Base Disorders II

TermWhat you need to know
★ Compensation“Tattoo on the inside of your eyeballs”: compensation will never fully correct the pH in a simple disorder.
★ Normal pHA normal pH with abnormal values does not mean there is no mixed problem (three of the six slide examples have a normal pH).
★ One lungOnly one respiratory disorder at a time; several metabolic disorders can coexist.
★ Big gapA big anion gap is always metabolic; respiratory disorders do not cause large gaps (slide 26: >20 suggests a primary metabolic disorder).
★ Winter formulaExpected carbon dioxide = 1.5 × bicarbonate + 8, ± 2. Above = concurrent respiratory acidosis; below = concurrent respiratory alkalosis.
★ Gap vs bicarbonateChange in gap (from 10) vs fall in bicarbonate (from 25): equal = simple; gap bigger = + metabolic alkalosis (only with a high gap); bicarbonate bigger = check chloride; = gap + chloride = high-gap + normal-gap acidosis.
★ AlbuminAdd 2.5 for every 1 g/dL below 4.5; hypoalbuminemia lowers the gap, so the gap must be corrected (slides 8, 48).
★ Acute vs chronicRespiratory acidosis: bicarbonate up 1 (acute) vs 3.5 (chronic) per 10 mm Hg of carbon dioxide.
★ Treat the cause“Golden rule”: find and treat the underlying condition; always circle back to the patient (slide 27). Stop respiratory depressants (narcotics, benzodiazepines); careful oxygen in chronic retainers; do not overcorrect an alkalosis.
★ CalculateShe expects the calculations (gap, corrected gap, Winter, compensation), not the nomogram (slide 25); lab values come with reference ranges and the albumin.
Lighter touchRenal physiology detail (slides 20–21); plasma cell dyscrasias and bromide; licorice; the less common normal-gap causes.

Definitions, Buffers & Electrolytes

TermWhat you need to know
DefinitionsSimple (primary) disorder = one primary disturbance + its compensation; mixed = more than one primary disturbance at once (slide 4).
PotassiumAlkalosis: hydrogen ions out of cells, potassium in → hypokalemia. Acidosis: hydrogen ions in, potassium out → hyperkalemia (slide 5).
OxygenAlkalosis: hemoglobin holds oxygen tighter → less delivered to tissues. Acidosis: lower affinity → more delivered (slide 5).
AcidsVolatile (carbonic acid, from fats and carbohydrates) → lungs. Nonvolatile (proteins, ingested sulfates and phosphates) → kidneys (slide 13).
BuffersRenal/respiratory = most important overall; carbon dioxide adjusts quickly, bicarbonate slowly (hours to days). Intracellular buffers (proteins, phosphate, hemoglobin) do 60–70%; bone (slides 14, 19).
KidneyCannot excrete free hydrogen ions: buffered by ammonium and titratable acids (major one: hydrogen phosphate); urinary bicarbonate should be 0; urine pH can fall to 4.0 (slides 20–21).
LungsBrain stem senses cerebral pH; more carbon dioxide → faster breathing. Hyperventilation ↓ carbon dioxide; hypoventilation ↑ it (slides 18, 22).

Stepwise Method

TermWhat you need to know
1Arterial blood gas and electrolytes together; compare the two bicarbonates to verify accuracy (slide 56).
2pH: acidosis or alkalosis? Carbon dioxide and bicarbonate: respiratory or metabolic?
3Calculate the anion gap; correct for hypoalbuminemia.
4Estimate the compensation: appropriate? Excess or inadequate = mixed disorder (slides 26, 57).
5Which mixed disorders? pH, carbon dioxide, bicarbonate; change in gap, bicarbonate and chloride.
6Does it match the clinical picture? If there is a second disorder, find and treat both causes (slides 56–57, 63).

Respiratory Acidosis

TermWhat you need to know
What↑ carbon dioxide from decreased alveolar ventilation, NEVER increased production (slide 31).
Causes (slide 32)Central nervous system depression (sedatives, central event); neuromuscular and musculoskeletal disorders (myopathies, neuropathies, kyphoscoliosis, Guillain-Barré syndrome, myasthenia gravis, botulism, polymyositis); hemothorax, pneumothorax; flail chest; acute airway obstruction (upper airway, laryngospasm, bronchospasm); severe pneumonia or pulmonary edema; ventilator dysfunction; obesity-hypoventilation syndrome; pleural effusion; chronic obstructive pulmonary disease, acute respiratory distress syndrome. (Slide 32 also lists pulmonary embolism; slide 39 lists lung disease under respiratory alkalosis, so its direction is not keyed.)
Acute or chronicBicarbonate up 1 per 10 mm Hg (acute) vs 3.5 after 24–48 hours (chronic). Slide 35: carbon dioxide 80 → compare the measured bicarbonate with each expected value.
TreatUnderlying condition; stop respiratory depressants (narcotics, benzodiazepines). Carbon dioxide >80 with oxygen <40: ventilate (airway, ventilator), clear secretions, oxygen (slide 36).
ChronicSame, with careful oxygen: a rapidly falling carbon dioxide can trigger alkalosis complications (arrhythmias, reduced cerebral perfusion, seizures) (slide 37).

Respiratory Alkalosis

TermWhat you need to know
WhatpH >7.45 with ↓ carbon dioxide (slide 38).
Causes (slide 39)Anxiety; hypoxia; high altitude (physiologic); lung disease with or without hypoxia; decreased lung compliance (interstitial fibrosis); central nervous system disease; catastrophic central event (intracerebral hemorrhage).
Treat (slide 40)Mild (pH <7.50): usually none. Treat pain, anxiety, fever, infection or salicylate overdose; mindful breathing. On a ventilator: decrease minute volume (fewer breaths or smaller tidal volume).

Metabolic Acidosis

TermWhat you need to know
WhatExcess acid to buffer or net loss of bicarbonate; compensation = lower carbon dioxide by breathing more (slide 41).
SymptomsMostly the underlying disorder; compensatory hyperventilation; Kussmaul breathing in severe acidosis: deep, regular, sighing breaths (slide 42).
Raised gapMUDPILES + renal failure, rhabdomyolysis; Big 4: ketoacidosis, lactic acidosis, renal failure, toxins (slides 44–45).
Normal gapUSEDCAR; slide 46: “Think: gastrointestinal bicarbonate loss, renal tubular acidosis”.
Respiratory partnerWinter formula: above = + respiratory acidosis; below = + respiratory alkalosis (slide 49).
Metabolic partnerChange in gap vs change in bicarbonate (slide 50).

Metabolic Alkalosis

TermWhat you need to know
WhatpH >7.45, hydrogen ions ↓, bicarbonate ↑; less common than metabolic acidosis (slide 51).
SymptomsMostly the underlying disorder; hypokalemia → weakness, hyporeflexia; rarely tetany and neuromuscular irritability (slide 52).
Urine chloride<25 = saline-responsive; >40 = saline-unresponsive (then normotensive or hypertensive).
Treat (slide 54)Underlying condition; unclear cause → urine chloride; stop diuretics, nasogastric suction, corticosteroids; replace fluid and potassium; don’t overcorrect!
Steroids (slide 55)Lower the dose or switch to less mineralocorticoid activity (consider prednisone or methylprednisolone vs cortisone or hydrocortisone). Consider excess alkali, glucose after starvation, high-dose penicillin, profound potassium depletion, endogenous mineralocorticoid excess.